Document:

Exhibit 10.5

 

 

Name: __________________

 

Copy No.: ________________

 

 

 

CONFIDENTIAL PRIVATE
PLACEMENT MEMORANDUM

 

For Accredited Investors Only

_______________________________________________________

 

 

Odyssey Group International, Inc.

 

A Nevada Corporation

 

 

 

 

CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM

 

 

 

 

For Accredited Investors Only

 

 

 

 

March 5, 2021

 

 

 

 

 

 

This Confidential Private Placement Memorandum
is for the

confidential use of the Offeree named on
this cover page

and may not be reproduced in whole or in
part.

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Odyssey Group International, Inc.

Common Stock

 

 

THIS IS A “NO MINIMUM” COMMON
STOCK WILL BE ISSUED TO

PURCHASERS UPON ACCEPTANCE BY THE COMPANY
OF EACH INDIVIDUAL

SUBSCRIPTION

 

 

MAXIMUM OFFERING: $2,500,000

Purchase Price: Set forth below

__________________________________________

 

Odyssey Group International, Inc., a Nevada
Corporation (“Odyssey,” the “Issuer,” the “Company,”), hereby offers on
a “No Minimum” basis (the “Offering”) up to Three Million one Hundred Twenty-Five Thousand (3,125,000)
Units consisting of an equal number of Shares of the Company’s Common Stock per Unit (the “Common Stock” or each
“Common Stock” or “Securities”) at a purchase price per share of Common Stock to be priced at a twenty
percent (20%) discount to market priced on the close of trading on Tuesday, March 2, 2021. The price will reflect the highest price
traded on that day. The Company has set a floor of Eighty Cents ($0.80) per share and a ceiling of One Dollar ($1.00) price per
share of restricted common stock and warrants to purchase up to an equal number of Shares of the Company’s Common Stock per
Unit shares of Common Stock at a per share purchase price of Two Dollars ($2.00) per share. The warrants have a term of One (1)
year.

 

This Offering is being made on a “No
Minimum” basis, meaning no minimum amount of money must be raised. Upon clearance of the funds on deposit and approval of
the subscription by the Company, the Shares will be promptly distributed to the investors. There is no guarantee that the
Issuer will raise all of the funds necessary to implement the business plan and your entire investment could be lost. All net proceeds
from the sale of the Common Stock being offered will accrue to the Company. The period of time in which the Issuer will accept
subscriptions for up to Three Million one Hundred Twenty-Five Thousand (3,125,000) Units will begin on the date of this Confidential
Private Placement Memorandum (the “Memorandum”) and will terminate on March 5, 2021, with a one (1) year option
to extend at the sole discretion of the Company (the “Offering Period”).

 

THERE CAN BE NO GUARANTEE THAT THE INVESTOR
WILL RECEIVE A RETURN OF ALL OR PART OF THEIR INITIAL CAPITAL CONTRIBUTION OR THAT THEY WILL RECEIVE A RETURN ON THEIR INVESTMENT.

 

THE SECURITIES OFFERED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS
OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND SUCH STATE LAWS. THESE SECURITIES MAY NOT BE TRANSFERRED OR SOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND SUCH STATE
LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. The Common Stocks will be offered
and sold solely to “Accredited Investors” (AS SUCH TERM IS DEFINED IN RULE 501 OF REGULATION D UNDER
THE SECURITIES ACT).

 

THE SECURITIES OFFERED HEREBY INVOLVE A
HIGH DEGREE OF RISK AND ARE SUBJECT TO SUBSTANTIAL RESTRICTIONS ON TRANSFERABILITY AND RESALE AND SHOULD BE PURCHASED ONLY BY PERSONS
WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT AND BEAR THE FINANCIAL RISK OF INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. SEE
“RISK FACTORS.”

 

The date of this Confidential Private
Placement Memorandum is March 5, 2021.

 

 

 

 

    	 	 	 

     

    

 

IMPORTANT INVESTOR NOTICES

 

Confidentiality

 

THE INFORMATION
CONTAINED IN THIS PRIVATE PLACEMENT MEMORANDUM AND THE EXHIBITS ARE CONFIDENTIAL AND PROPRIETARY TO THE ISSUER AND ARE BEING SUBMITTED
TO PROSPECTIVE INVESTORS SOLELY FOR SUCH INVESTOR’S CONFIDENTIAL USE WITH THE EXPRESS UNDERSTANDING THAT, WITHOUT THE PRIOR
WRITTEN PERMISSION OF THE ISSUER, SUCH PROSPECTIVE INVESTORS WILL NOT RELEASE THIS DOCUMENT OR DISCUSS THE INFORMATION CONTAINED
HEREIN OTHER THAN WITH SUCH PROSPECTIVE INVESTOR’S LEGAL, TAX OR ACCOUNTING ADVISERS OR MAKE REPRODUCTIONS OF OR OTHERWISE
USE THIS PRIVATE PLACEMENT MEMORANDUM OR ITS EXHIBITS FOR ANY PURPOSE OTHER THAN EVALUATING A POTENTIAL INVESTMENT IN THE SECURITIES
DESCRIBED HEREIN.

 

THIS
PRIVATE PLACEMENT MEMORANDUM CONTAINS CERTAIN FINANCIAL AND OTHER INFORMATION WHICH IS MATERIAL, NONPUBLIC INFORMATION AND SHOULD
BE TREATED AS CONFIDENTIAL. RECEIPT AND ACCEPTANCE OF THIS PRIVATE PLACEMENT MEMORANDUM AND ITS EXHIBITS CONSTITUTES THE RECIPIENT’S
ACKNOWLEDGMENT THAT THE INFORMATION CONTAINED HEREIN WILL BE MAINTAINED IN STRICT CONFIDENCE BY THE RECIPIENT.

 

A PROSPECTIVE
INVESTOR, BY ACCEPTING DELIVERY OF THIS PRIVATE PLACEMENT MEMORANDUM AND ITS EXHIBITS, FURTHER AGREES TO PROMPTLY RETURN, AT THE
ISSUER’S REQUEST, THIS PRIVATE PLACEMENT MEMORANDUM AND ANY OTHER DOCUMENTS OR INFORMATION FURNISHED IF THE PROSPECTIVE INVESTOR
ELECTS NOT TO PURCHASE ANY OF THE COMMON STOCK DESCRIBED HEREIN.

 

Securities Information

 

THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS
WHO HAVE SUBSTANTIAL FINANCIAL RESOURCES, WHO DO NOT ANTICIPATE THAT THEY WILL NEED TO LIQUIDATE THEIR INVESTMENT IN THE ISSUER
IN THE FORESEEABLE FUTURE, AND WHO UNDERSTAND THE TERMS OF THE OFFERING AND RISK FACTORS ASSOCIATED WITH THIS INVESTMENT.

 

NO
PERSON IS AUTHORIZED IN CONNECTION WITH THE OFFERING TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATION NOT CONTAINED IN THIS
MEMORANDUM AND, IF GIVEN OR MADE, SUCH OTHER INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED. NO
OFFERING LITERATURE OR ADVERTISING IN ANY FORM IS AUTHORIZED FOR USE IN CONNECTION WITH THE OFFERING EXCEPT FOR THIS MEMORANDUM,
THE EXHIBITS HERETO, AND ANY SUPPLEMENT OR AMENDMENT HERETO. ONLY THOSE REPRESENTATIONS SET FORTH IN THIS MEMORANDUM MAY BE RELIED
UPON IN CONNECTION WITH THE OFFERING. NO REPRESENTATIONS, WARRANTIES OR ASSURANCES OF ANY KIND ARE MADE OR SHOULD BE INFERRED
WITH RESPECT TO THE ECONOMIC RETURN, IF ANY, THAT MAY ACCRUE TO AN INVESTOR OR THE ISSUER.

 

THIS OFFERING IS BEING MADE SOLELY TO “ACCREDITED
INVESTORS,” AS SUCH TERM IS DEFINED IN RULE 501 OF REGULATION D UNDER THE SECURITIES ACT. THE SECURITIES OFFERED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT, OR REGISTERED OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS, IN RELIANCE UPON
EXEMPTIONS THEREFROM. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATIONS OR EXEMPTIONS
THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE
PERIOD OF TIME.

 

 

 

    	 	i	 

     

    

 

THIS MEMORANDUM DOES NOT CONSTITUTE AN
OFFER OR SOLICITATION OF AN OFFER TO ANY PERSON OR IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION IS UNLAWFUL OR NOT AUTHORIZED.
EACH PERSON WHO ACCEPTS DELIVERY OF THIS MEMORANDUM AGREES TO RETURN IT AND ALL RELATED DOCUMENTS IF SUCH PERSON DOES NOT PURCHASE
ANY OF THE SECURITIES DESCRIBED HEREIN.

 

THIS INVESTMENT INVOLVES A HIGH DEGREE
OF RISK. PLEASE READ THIS ENTIRE MEMORANDUM. IT CONTAINS INFORMATION THE INVESTOR SHOULD KNOW BEFORE PURCHASING ANY COMMON STOCK
IN THIS OFFERING. IN MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF
THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED, APPROVED OR DISAPPROVED BY ANY
FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT PASSED UPON OR
CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

NEITHER THE DELIVERY OF THIS MEMORANDUM
AT ANY TIME NOR ANY SALE OF SECURITIES HEREUNDER SHALL IMPLY THAT INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT
TO ITS DATE. THE ISSUER EXTENDS TO EACH PROSPECTIVE INVESTOR (AND TO ITS REPRESENTATIVE, ACCOUNTANT OR LEGAL COUNSEL, IF ANY) THE
OPPORTUNITY, PRIOR TO ITS PURCHASE OF COMMON STOCK, TO ASK QUESTIONS OF AND RECEIVE ANSWERS FROM THE ISSUER CONCERNING THE OFFERING
AND TO OBTAIN ADDITIONAL INFORMATION, TO THE EXTENT THE ISSUER POSSESSES THE SAME OR CAN ACQUIRE IT WITHOUT UNREASONABLE EFFORT
OR EXPENSE, IN ORDER TO VERIFY THE ACCURACY OF THE INFORMATION SET FORTH HEREIN. ALL SUCH ADDITIONAL INFORMATION SHALL ONLY BE
PROVIDED IN WRITING AND IDENTIFIED AS SUCH BY THE ISSUER THROUGH ITS DULY AUTHORIZED OFFICERS; NO ORAL INFORMATION OR INFORMATION
PROVIDED BY ANY BROKER OR THIRD PARTY MAY BE RELIED UPON.

 

Private Placement Memorandum

 

THIS PRIVATE PLACEMENT MEMORANDUM HAS BEEN
PREPARED BY THE ISSUER AND CONTAINS SUMMARIES OF CERTAIN DOCUMENTS, WHICH ARE BELIEVED TO BE ACCURATE, BUT REFERENCE IS MADE TO
SUCH DOCUMENTS FOR COMPLETE INFORMATION CONCERNING THE RIGHTS AND OBLIGATIONS OF THE PARTIES THERETO. THE ISSUER FROM SUCH OTHER
SOURCES HAS OBTAINED OTHER INFORMATION CONTAINED HEREIN AS THE ISSUER DEEMED ACCURATE AND RELIABLE. THE MEMORANDUM DOES NOT PURPORT
TO CONTAIN ALL OF THE INFORMATION THAT MAY BE REQUIRED TO EVALUATE AN INVESTMENT IN THE ISSUER, AND ANY POTENTIAL INVESTOR SHOULD
CONDUCT THE INVESTOR’S OWN INDEPENDENT ANALYSIS OF THE ISSUER AND THE INVESTMENT.

 

THIS MEMORANDUM CONSTITUTES AN OFFER ONLY
IF A NUMBER IN INK OR TYPE WRITTEN APPEARS IN THE UPPER RIGHT CORNER OF THE FRONT COVER. THIS MEMORANDUM SUPERSEDES ANY DOCUMENTS
PREVIOUSLY SUPPLIED TO POTENTIAL INVESTORS CONCERNING THE ISSUER AND THE TERMS AND CONDITIONS OF THE OFFERING BEING MADE HEREBY.

 

PROSPECTIVE INVESTORS SHOULD NOT CONSTRUE
THE CONTENTS OF THIS MEMORANDUM AS INVESTMENT, LEGAL, BUSINESS, OR TAX ADVICE. EACH INVESTOR SHOULD CONTACT HIS OWN ADVISERS REGARDING
THE APPROPRIATENESS OF THIS INVESTMENT AND THE TAX CONSEQUENCES THEREOF, WHICH MAY DIFFER DEPENDING ON AN INVESTOR’S PARTICULAR
FINANCIAL SITUATION. IN NO EVENT SHOULD THIS MEMORANDUM BE DEEMED OR CONSIDERED TO BE TAX ADVICE PROVIDED BY THE ISSUER.

 

 

 

    	 	ii	 

     

    

 

ODYSSEY GROUP INTERNATIONAL, INC.

OFFERING OF UNITS CONSISTING OF COMMON
STOCK AND A RIGHT TO PURCHASE COMMON STOCK

THIS IS A “NO MINIMUM” COMMON
STOCK WILL BE ISSUED TO

PURCHASERS UPON ACCEPTANCE BY THE COMPANY
OF EACH INDIVIDUAL

SUBSCRIPTION

 

Maximum Offering: Three Million one Hundred
Twenty-Five Thousand (3,125,000) Shares of Units to Purchase a Share of Common Stock and the Right to Purchase a Share of Common
Stock for the aggregate amount of Two Million Five Hundred Thousand Dollars ($2,500,000)

 

 

IMPORTANT NOTICES

 

 

THIS
MEMORANDUM IS BEING USED BY THE COMPANY IN CONNECTION WITH THE PRIVATE PLACEMENT OF COMMON STOCK OF COMMON STOCK (THE “SECURITIES”
OR THE “COMMON STOCK”) PURSUANT TO AN EXEMPTION FROM REGISTRATION CONTAINED IN SECTION 4(A)(2) OF THE SECURITIES
ACT OF 1933 (THE “SECURITIES ACT”) OF REGULATION D THEREUNDER AS WELL AS APPLICABLE STATE AND FOREIGN SECURITIES LAWS.

 

THIS MEMORANDUM IS SUBMITTED ON A CONFIDENTIAL
BASIS FOR THE USE SOLELY IN CONNECTION WITH THE CONSIDERATION OF THE PURCHASE OF THE SECURITIES DESCRIBED HEREIN. THE RECEIPT OF
THIS MEMORANDUM CONSTITUTES THE AGREEMENT ON THE PART OF THE RECIPIENT HEREOF AND ITS REPRESENTATIVES TO MAINTAIN THE CONFIDENTIALITY
OF THE INFORMATION CONTAINED HEREIN. THIS MEMORANDUM MAY NOT BE REPRODUCED IN WHOLE OR IN PART AND ITS USE FOR ANY PURPOSE OTHER
THAN TO EVALUATE AN INVESTMENT IN THE SECURITIES IS NOT AUTHORIZED. THE CONTENTS OF THIS MEMORANDUM MAY NOT BE COMMUNICATED TO
ANY THIRD PARTY WITHOUT THE PRIOR WRITTEN CONSENT OF THE COMPANY. THE RECEIPT OF THIS MEMORANDUM CONSTITUTES THE AGREEMENT ON THE
PART OF THE RECIPIENT TO THE FOREGOING.

 

THIS MEMORANDUM DOES NOT CONSTITUTE AN
OFFER TO SELL OR SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OTHER THAN THE SECURITIES OFFERED HEREBY, NOR DOES IT CONSTITUTE
AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY FROM ANY PERSON IN ANY STATE OR OTHER JURISDICTION IN WHICH SUCH OFFER OR
SOLICITATION WOULD BE UNLAWFUL, OR IN WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT QUALIFIED TO DO SO, OR TO A PERSON
TO WHOM IT IS UNLAWFUL TO MAKE SUCH AN OFFER OR SOLICITATION.

 

THIS INVESTMENT INVOLVES A HIGH DEGREE
OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN
AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS PURCHASING THE SECURITIES MUST UNDERSTAND THAT SUCH INVESTMENT IS
ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. SEE “RISK FACTORS.”

 

THE SECURITIES OFFERED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES OR BLUE-SKY LAWS AND ARE BEING OFFERED AND
SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND STATE SECURITIES OR BLUE-SKY LAWS. ACCORDINGLY,
THE SECURITIES CANNOT BE OFFERED, SOLD, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. IN
ADDITION, THE SECURITIES CANNOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE APPLICABLE STATE SECURITIES OR BLUE-SKY
LAWS. CERTIFICATES FOR THE SECURITIES WILL BEAR A LEGEND TO THAT EFFECT. THE EXEMPTION UNDER THE SECURITIES ACT PROVIDED BY RULE
144 MAY NOT BE AVAILABLE. ALL INVESTORS WILL BE REQUIRED TO UNDERTAKE THAT THEY WILL NOT RESELL THE SECURITIES EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION FROM REGISTRATION. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED
BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING
AUTHORITIES PASSED UPON THE MERITS OF THIS OFFERING OR THE ADEQUACY OR ACCURACY OF THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY
IS UNLAWFUL. INVESTORS SHOULD BE AWARE THAT THEY MIGHT BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE
PERIOD OF TIME.

 

 

 

    	 	iii	 

     

    

 

EACH
PROSPECTIVE INVESTOR MUST COMPLY WITH ALL APPLICABLE LAWS AND REGULATIONS IN FORCE IN ANY JURISDICTION IN WHICH IT PURCHASES,
OFFERS OR SELLS THE SECURITIES AND MUST OBTAIN ANY CONSENT, APPROVAL OR PERMISSION REQUIRED BY IT FOR THE PURCHASE, OFFER OR SALE
BY IT OF THE SECURITIES UNDER THE LAWS AND REGULATIONS IN FORCE IN ANY JURISDICTION TO WHICH IT IS SUBJECT OR IN WHICH IT MAKES
SUCH PURCHASES, OFFERS OR RESALES, AND THE COMPANY SHALL NOT HAVE ANY RESPONSIBILITY THEREFORE.

 

THE OFFERING PRICE OF THE SECURITIES HAS
BEEN DETERMINED BY THE COMPANY AND DOES NOT NECESSARILY BEAR ANY RELATIONSHIP TO THE ASSETS, BOOK VALUE OR POTENTIAL EARNINGS OF
THE COMPANY OR ANY OTHER RECOGNIZED CRITERIA OF VALUE.

 

NO PERSON OR ENTITY MAY PURCHASE ANY COMMON
STOCK OF THE SECURITIES HEREUNDER UNLESS SUCH PERSON OR ENTITY IS AN “ACCREDITED INVESTOR,” AS THAT TERM IS DEFINED
IN SECTION 501(A) OF REGULATION D PROMULGATED UNDER THE SECURITIES ACT. THE COMPANY IS RELYING ON THE REPRESENTATIONS AND WARRANTIES
SET FORTH BY EACH SUBSCRIBER IN THE SUBSCRIPTION AGREEMENT AND THE ACCREDITED INVESTOR QUESTIONNAIRE ATTACHED HERETO TO DETERMINE
THE APPLICABILITY TO THIS OFFERING OF EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

 

PROSPECTIVE INVESTORS ARE NOT TO CONSTRUE
THE CONTENTS OF THIS MEMORANDUM OR ANY OF THE EXHIBITS OR ANY PRIOR OR SUBSEQUENT COMMUNICATIONS FROM THE COMPANY OR ANY OF ITS
OFFICERS, EMPLOYEES OR AGENTS AS INVESTMENT, LEGAL OR TAX ADVICE.

 

To
ensure compliance with requirements imposed by the IRS, THE COMPANY AND THE COMPANY’S TAX AND LEGAL ADVISERS inform the investor
that any UNITED STATES federal tax advice contained in this communication (including any attachments) is not intended or written
to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing
or recommending to another party any transaction or matter addressed herein.

 

IN MAKING AN INVESTMENT DECISION, INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THIS OFFERING, INCLUDING THE MERITS AND THE RISKS INVOLVED.
THE TAX IMPLICATIONS OF AN INVESTMENT IN THE SECURITIES HAVE NOT BEEN CONSIDERED IN THIS MEMORANDUM OR ANY OF THE EXHIBITS HERETO.
EACH PROSPECTIVE INVESTOR SHOULD CONSULT THE INVESTOR’S OWN COUNSEL, ACCOUNTANT AND OTHER PROFESSIONAL ADVISER AS TO INVESTMENT,
LEGAL, TAX AND OTHER RELATED MATTERS CONCERNING THE INVESTOR’S PROPOSED INVESTMENT.

 

THE
COMPANY HAS ESTABLISHED INVESTOR SUITABILITY STANDARDS FOR PURCHASERS OF THE SECURITIES. EACH INVESTOR MUST REPRESENT TO THE COMPANY
THAT: (A) SUCH INVESTOR HAS SUCH KNOWLEDGE AND EXPERIENCE IN FINANCIAL AND BUSINESS MATTERS SO AS TO BE CAPABLE OF EVALUATING THE
MERITS AND RISKS OF HIS, HER OR ITS INVESTMENT IN THE SECURITIES AND SUCH INVESTOR IS ABLE TO BEAR THE ECONOMIC RISKS OF AN INVESTMENT
IN THE SECURITIES AND TO AFFORD THE COMPLETE LOSS OF THE INVESTMENT; (B) THE SECURITIES TO BE ACQUIRED BY SUCH INVESTOR
IS BEING ACQUIRED FOR HIS, HER OR THE INVESTOR’S OWN ACCOUNT AND WITHOUT A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY
DISTRIBUTION THEREOF OR ANY INTEREST THEREIN; AND (C) SUCH INVESTOR HAS HAD ACCESS TO SUCH FINANCIAL AND OTHER INFORMATION, AND
HAS BEEN AFFORDED THE OPPORTUNITY TO ASK SUCH QUESTIONS OF THE REPRESENTATIVES OF THE COMPANY AND RECEIVE ANSWERS THERETO, AS SUCH
INVESTOR HAS DEEMED NECESSARY IN CONNECTION WITH HIS, HER OR ITS DECISION TO PURCHASE THE SECURITIES.

 

CERTAIN PROVISIONS OF VARIOUS AGREEMENTS
ARE SUMMARIZED IN THIS MEMORANDUM, BUT PROSPECTIVE INVESTORS SHOULD NOT ASSUME THAT SUCH SUMMARIES ARE COMPLETE. SUCH SUMMARIES
ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO THE TEXTS OF THE ORIGINAL DOCUMENTS, WHICH WILL BE MADE AVAILABLE BY THE COMPANY
UPON REQUEST BY PROSPECTIVE INVESTORS.

 

 

 

    	 	iv	 

     

    

 

THIS MEMORANDUM (INCLUDING THE EXHIBITS)
CONTAINS FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY,
AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY
AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THIS MEMORANDUM, THE WORDS “ESTIMATE,” “PROJECT,”
“BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED
TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING STATEMENTS REFLECT MANAGEMENT’S
CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL
RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE
RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE OF THIS MEMORANDUM. THE COMPANY DOES NOT UNDERTAKE
ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER THE DATE OF THIS MEMORANDUM
OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS. NEITHER THE DELIVERY OF THIS MEMORANDUM AT ANY TIME, NOR ANY SALES HEREUNDER,
SHALL UNDER ANY CIRCUMSTANCES CREATE AN IMPLICATION THAT THE INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT
TO THE DATE HEREOF.

 

THE INFORMATION CONTAINED IN THIS MEMORANDUM
MAY CHANGE OR VARY AFTER THE DATE ON THE FRONT OF THE MEMORANDUM. THE COMPANY UNDERTAKES TO MAKE AVAILABLE TO EVERY INVESTOR DURING
THE COURSE OF THIS TRANSACTION AND PRIOR TO SALE OF SECURITIES THE OPPORTUNITY TO ASK QUESTIONS OF AND RECEIVE ANSWERS FROM THE
COMPANY CONCERNING THE TERMS AND CONDITIONS OF THIS OFFERING AND TO OBTAIN ANY APPROPRIATE, ADDITIONAL INFORMATION NECESSARY TO
VERIFY THE ACCURACY OF THE INFORMATION CONTAINED IN THIS MEMORANDUM.

 

THE INFORMATION PRESENTED HEREIN WAS PREPARED
BY THE COMPANY SOLELY FOR THE USE BY PROSPECTIVE INVESTORS IN CONNECTION WITH THIS OFFERING. NO REPRESENTATIONS OR WARRANTIES ARE
MADE AS TO THE ACCURACY OR COMPLETENESS OF THE INFORMATION CONTAINED HEREIN, AND NOTHING CONTAINED HEREIN IS OR SHOULD BE RELIED
UPON AS A PROMISE OR REPRESENTATION AS TO THE FUTURE PERFORMANCE OF THE COMPANY. NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION
OR TO MAKE ANY REPRESENTATION CONCERNING THE COMPANY OR THE SECURITIES OFFERED HEREBY OTHER THAN THOSE CONTAINED IN THIS MEMORANDUM
AND, IF GIVEN OR MADE, SUCH OTHER INFORMATION OR REPRESENTATION SHOULD NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY.

 

THE
SECURITIES ARE BEING OFFERED BY THE COMPANY, SUBJECT TO PRIOR SALE, ACCEPTANCE OF AN OFFER TO PURCHASE, WITHDRAWAL, CANCELATION,
MODIFICATION OF THIS OFFERING WITHOUT NOTICE OR APPROVAL OF CERTAIN LEGAL MATTERS BY THE COMPANY’S LEGAL COUNSEL. THE
COMPANY RESERVES THE RIGHT IN ITS SOLE AND UNFETTERED DISCRETION AND FOR ANY REASON WHATSOEVER TO MODIFY, AMEND AND/OR WITHDRAW
ALL OR A PORTION OF THE OFFERING AND/OR ACCEPT OR REJECT IN WHOLE OR IN PART ANY PROSPECTIVE INVESTMENT IN THE SECURITIES OR TO
ALLOT TO ANY PROSPECTIVE INVESTOR LESS THAN THE AMOUNT OF COMMON STOCK OF THE SECURITIES SUCH INVESTOR DESIRES TO PURCHASE EVEN
IF SUCH INVESTOR SATISFIES ALL OF THE SUITABILITY STANDARDS DISCUSSED IN THIS MEMORANDUM. IF THE PROSPECTIVE INVESTOR RECEIVING
THIS MEMORANDUM DOES NOT SUBMIT AN OFFER TO PURCHASE, OR IF SUCH OFFER IS SUBMITTED BUT NOT ACCEPTED BY THE COMPANY, THE PROSPECTIVE
INVESTOR AGREES TO RETURN PROMPTLY THIS MEMORANDUM AND ANY ACCOMPANYING DOCUMENTS PROVIDED IN CONNECTION HEREWITH.

 

EXCEPT AS OTHERWISE INDICATED, THIS MEMORANDUM
SPEAKS AS OF THE DATE APPEARING ON THE COVER PAGE HEREOF. NEITHER THE DELIVERY NOR THE PURCHASE OF THE SECURITIES SHALL, UNDER
ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THERE HAS NOT BEEN ANY CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE AT WHICH
THE INFORMATION IS GIVEN HEREIN.

 

THESE SUBSCRIPTION DOCUMENTS SHOULD BE
READ IN CONJUNCTION WITH THE EXHIBITS HERETO, INCLUDING THE INVESTMENT CONSIDERATIONS AND RISK FACTORS CONTAINED HEREIN.

 

 

 

    	 	v	 

     

    

 

EACH
OFFEREE MAY, IF THE OFFEREE SO DESIRES, MAKE INQUIRIES OF THE COMPANY WITH RESPECT TO THE COMPANY’S BUSINESS OR ANY OTHER
MATTERS RELATING TO THE COMPANY AND ANY INVESTMENT IN THE SECURITIES THEREOF, AND MAY OBTAIN ANY ADDITIONAL INFORMATION
WHICH SUCH PERSON DEEMS TO BE NECESSARY IN CONNECTION WITH MAKING AN INVESTMENT DECISION IN ORDER TO VERIFY THE ACCURACY OF THE
INFORMATION CONTAINED IN THESE SUBSCRIPTION DOCUMENTS OR ANY OTHER DOCUMENTS DELIVERED TO THE OFFEREE BY THE COMPANY (TO THE EXTENT
THAT THE COMPANY POSSESSES SUCH INFORMATION OR CAN ACQUIRE IT WITHOUT UNREASONABLE EFFORT OR EXPENSE). IN CONNECTION WITH SUCH
INQUIRY, ANY PERTINENT DOCUMENTS WHICH ANY OFFEREE WISHES TO REVIEW WILL BE MADE AVAILABLE FOR INSPECTION AND COPYING OR PROVIDED,
UPON REQUEST, SUBJECT TO THE OFFEREE’S AGREEMENT TO MAINTAIN SUCH INFORMATION IN CONFIDENCE AND TO RETURN THE SAME DOCUMENTS
TO THE COMPANY IF THE RECIPIENT DOES NOT PURCHASE THE SECURITIES OFFERED HEREUNDER.

 

IT
IS THE RESPONSIBILITY OF ANY PERSON WISHING TO PURCHASE THE COMMON STOCK TO SATISFY HIMSELF, HERSELF, OR ITSELF, HERSELF
OR ITSELF AS TO THE FULL OBSERVATION OF THE LAWS OF ANY RELEVANT TERRITORY OUTSIDE THE UNITED STATES IN CONNECTION WITH ANY SUCH
PURCHASE, INCLUDING OBTAINING ANY REQUIRED GOVERNMENTAL OR OTHER CONSENTS OR OBSERVING ANY OTHER APPLICABLE FORMALITIES.

 

NASAA UNIFORM LEGEND

 

IN MAKING AN INVESTMENT DECISION INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE
SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING
AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS
A CRIMINAL OFFENSE.

 

THESE SECURITIES ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY
MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

 

NOTICE TO RESIDENTS OF ALL STATES

 

THE
COMMON STOCK OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE AND ARE
BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH LAWS. THESE
SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.
INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
TIME.

 

IN
MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES
AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL
OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY
OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

 

 

    	 	vi	 

     

    

 

INFORMATION REQUIRED BY CERTAIN STATES’
SECURITIES LAWS

 

FOR RESIDENTS OF ALABAMA

 

THESE SECURITIES ARE OFFERED PURSUANT TO
A CLAIM OF EXEMPTION UNDER THE ALABAMA SECURITIES ACT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS NOT BEEN FILED
WITH THE ALABAMA SECURITIES COMMISSION. THE COMMISSION DOES NOT RECOMMEND NOR ENDORSE THE PURCHASE OF ANY SECURITIES, NOR DOES
IT PASS UPON THE ACCURACY OR COMPLETENESS OF THESE SUBSCRIPTION DOCUMENTS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

FOR RESIDENTS OF ALASKA

 

THE
SECURITIES OFFERED HAVE NOT BEEN REGISTERED WITH THE ADMINISTRATOR OF SECURITIES OF THE STATE OF ALASKA UNDER PROVISIONS
OF 3 AAC 08.500-3 AAC 08.506. THE INVESTOR IS ADVISED THAT THE ADMINISTRATOR HAS MADE ONLY A CURSORY REVIEW OF THE REGISTRATION
STATEMENT AND HAS NOT REVIEWED THIS DOCUMENT SINCE THE DOCUMENT IS NOT REQUIRED TO BE FILED WITH THE ADMINISTRATOR. THE FACT OF
REGISTRATION DOES NOT MEAN THAT THE ADMINISTRATOR HAS PASSED IN ANY WAY UPON THE MERITS, RECOMMENDED, OR APPROVED THE SECURITIES.
ANY REPRESENTATION TO THE CONTRARY IS A VIOLATION OF AS 45.55.170.

 

THE
INVESTOR MUST RELY ON THE INVESTOR'S OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THE
OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED, IN MAKING AN INVESTMENT DECISION ON THESE SECURITIES.

 

FOR RESIDENTS OF ARIZONA

 

THESE SECURITIES HAVE NOT BEEN REGISTERED
UNDER THE ARIZONA SECURITIES ACT IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION PURSUANT TO A.R.S. SECTION 44-1844 (1) AND THEREFORE
CANNOT BE RESOLD UNLESS THEY ARE ALSO REGISTERED OR UNLESS AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

 

FOR RESIDENTS OF ARKANSAS

 

THESE SECURITIES ARE OFFERED IN RELIANCE
UPON CLAIMS OF EXEMPTION UNDER THE ARKANSAS SECURITIES ACT AND SECTION 4(2) OF THE SECURITIES ACT OF 1933. A REGISTRATION STATEMENT
RELATING TO THESE SECURITIES HAS NOT BEEN FILED WITH THE ARKANSAS SECURITIES DEPARTMENT OR WITH THE SECURITIES AND EXCHANGE COMMISSION.
NEITHER THE DEPARTMENT NOR THE COMMISSION HAS PASSED UPON THE VALUE OF THESE SECURITIES, MADE ANY RECOMMENDATIONS AS TO THEIR PURCHASE,
APPROVED OR DISAPPROVED THIS OFFERING OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY
IS UNLAWFUL.

 

FOR RESIDENTS OF CALIFORNIA

 

THE SECURITIES OFFERED IN THESE SUBSCRIPTION
DOCUMENTS HAVE NOT BEEN QUALIFIED UNDER THE CALIFORNIA CORPORATE SECURITIES LAW OF 1968 IN RELIANCE UPON AN EXEMPTION FROM QUALIFICATION
PURSUANT TO CALIFORNIA CORPORATIONS Code § 25102(F). IN ADDITION, ALL PURCHASERS SHOULD BE AWARE THAT IT IS UNLAWFUL FOR SUCH
PURCHASERS TO CONSUMMATE A SALE OR TRANSFER ANY Common Stock OR INTEREST THEREIN, OR TO RECEIVE ANY CONSIDERATION THEREFORE, WITHOUT
THE PRIOR WRITTEN CONSENT OF THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA, EXCEPT AS PERMITTED IN THE COMMISSIONER’S
RULES.

 

 

    	 	vii	 

     

    

 

FOR RESIDENTS OF COLORADO

 

THIS INFORMATION IS DISTRIBUTED PURSUANT
TO AN EXEMPTION FOR SMALL OFFERINGS UNDER THE RULES OF THE COLORADO SECURITIES DIVISION. THE SECURITIES DIVISION HAS NEITHER REVIEWED
NOR APPROVED ITS FORM OR CONTENT. THE SECURITIES DESCRIBED MAY ONLY BE PURCHASED BY “ACCREDITED INVESTORS” AS DEFINED
BY RULE 501 OF SEC REGULATION D AND THE RULES OF THE COLORADO SECURITIES DIVISION.

 

FOR RESIDENTS OF CONNECTICUT

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE BANKING COMMISSIONER OF THE STATE OF CONNECTICUT NOR HAS THE COMMISSIONER PASSED UPON THE ACCURACY OR ADEQUACY
OF THE OFFERING. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF DELAWARE

 

IF
THE INVESTOR IS A DELAWARE RESIDENT,YOU ARE HEREBY ADVISED THAT THESE SECURITIES ARE BEING OFFERED IN A TRANSACTION EXEMPT FROM
THE REGISTRATION REQUIREMENTS OF THE DELAWARE SECURITIES ACT. THE SECURITIES CANNOT BE SOLD OR TRANSFERRED EXCEPT IN A TRANSACTION
WHICH IS EXEMPT UNDER THE SECURITIES ACT OR PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR IN A TRANSACTION
WHICH IS OTHERWISE IN COMPLIANCE WITH THE SECURITIES ACT.

 

FOR RESIDENTS OF THE DISTRICT OF COLUMBIA

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE SECURITIES BUREAU OF THE DISTRICT OF COLUMBIA NOR HAS THE COMMISSIONER PASSED UPON THE ACCURACY OR ADEQUACY
OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF FLORIDA

 

IF SALES ARE MADE TO FIVE OR MORE PERSONS
IN FLORIDA, AND THE INVESTOR PURCHASE SECURITIES HEREUNDER, THEN THE INVESTOR MAY VOID SUCH PURCHASE EITHER WITHIN THREE (3) DAYS
AFTER THE FIRST TENDER OF CONSIDERATION IS MADE BY THE INVESTOR TO THE ISSUER, AN AGENT OF THE ISSUER, OR AN ESCROW AGENT OR WITHIN
THREE (3) DAYS AFTER THE AVAILABILITY OF THIS PRIVILEGE COMMUNICATED TO YOU, WHICHEVER OCCURS LATER.

 

FOR RESIDENTS OF GEORGIA

 

THESE SECURITIES HAVE BEEN ISSUED OR SOLD
IN RELIANCE ON PARAGRAPH (13) OF Code § 10-5-9 OF THE ‘GEORGIA SECURITIES ACT OF 1973,’ AND MAY NOT BE SOLD OR
TRANSFERRED EXCEPT IN A TRANSACTION WHICH IS EXEMPT UNDER SUCH ACT OR PURSUANT TO AN EFFECTIVE REGISTRATION UNDER SUCH ACT.

 

FOR RESIDENTS OF HAWAII

 

NEITHER THIS PROSPECTUS NOR THE SECURITIES
DESCRIBED HEREIN HAVE BEEN APPROVED OR DISAPPROVED BY THE COMMISSIONER OF SECURITIES OF THE STATE OF HAWAII NOR HAS THE COMMISSIONER
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS.

 

 

 

    	 	viii	 

     

    

 

FOR RESIDENTS OF IDAHO

 

THESE SECURITIES EVIDENCED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE IDAHO SECURITIES ACT IN RELIANCE UPON EXEMPTION FROM REGISTRATION PURSUANT TO SECTION 30-1345(1)
OR (8) THEREOF AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT IN A TRANSACTION WHICH IS EXEMPT UNDER SAID ACT
OR PURSUANT TO AN EFFECTIVE REGISTRATION UNDER SAID ACT.

 

FOR RESIDENTS OF ILLINOIS

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE SECRETARY OF THE STATE OF ILLINOIS NOR HAS THE STATE OF ILLINOIS PASSED UPON THE ACCURACY OR ADEQUACY OF
THE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF INDIANA

 

THESE
SECURITIES ARE OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER SECTION 23-2-1-2 OF THE INDIANA SECURITIES LAW AND HAVE NOT
BEEN REGISTERED UNDER SECTION 23-2-1-3. THEY CANNOT THEREFORE BE RESOLD UNLESS THEY ARE REGISTERED UNDER SAID LAW OR UNLESS AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. A CLAIM OF EXEMPTION UNDER SAID LAW HAS BEEN FILED, AND IF SUCH EXEMPTION IS NOT DISALLOWED
SALES OF THESE SECURITIES MAY BE MADE; HOWEVER, UNTIL SUCH EXEMPTION IS GRANTED ANY OFFER MADE PURSUANT HERETO IS PRELIMINARY AND
SUBJECT TO MATERIAL CHANGE.

 

FOR RESIDENTS OF IOWA

 

THESE SECURITIES ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, IN THE
APPLICABLE STATE SECURITIES LAW, PURSUANT TO REGISTRATION FOR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE
REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

 

FOR RESIDENTS OF KANSAS

 

IF AN INVESTOR ACCEPTS AN OFFER TO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER SECTION 81-5-6 OF THE KANSAS SECURITIES ACT AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED, OR
RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

FOR RESIDENTS OF KENTUCKY

 

IF AN INVESTOR ACCEPTS AN OFFER TO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER RULE 808 OF THE KENTUCKY SECURITIES ACT AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED, OR RESOLD
EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

FOR RESIDENTS OF LOUISIANNA

 

IF AN INVESTOR ACCEPTS AN OFFERTO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER RULE 1 OF THE LOUISIANA SECURITIES LAW AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED, OR RESOLD
EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

 

 

    	 	ix	 

     

    

 

FOR RESIDENTS OF MAINE

 

THE
SECURITIES ARE BEING SOLD PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE BANK SUPERINTENDENT OF THE STATE OF MAINE
UNDER SECTION 10502(2)(R) OF TITLE 32 OF THE MAINE REVISED STATUTES. THESE SECURITIES MAY BE DEEMED RESTRICTED SECURITIES AND AS
SUCH THE HOLDER MAY NOT BE ABLE TO RESELL THE SECURITIES UNLESS PURSUANT TO REGISTRATION UNDER STATE OR FEDERAL SECURITIES LAWS
OR UNLESS AN EXEMPTION UNDER SUCH LAWS EXIST.

 

FOR RESIDENTS OF MARYLAND

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
OR OTHER DOCUMENT HAVE BEEN ISSUED PURSUANT TO A CLAIM OF EXEMPTION FROM THE REGISTRATION PROVISIONS OF FEDERAL AND STATE SECURITIES
LAWS AND MAY NOT BE SOLD OR TRANSFERRED WITHOUT COMPLIANCE WITH THE REGSTRATION PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES
LAWS OR APPLICABLE EXEMPTIONS THEREFROM.

 

FOR RESIDENTS OF MASSACHUCETTS

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE SECURITIES DIVISION OF THE COMMONWEALTH OF MASSACHUSETTS NOR HAS THE SECRETARY OF THE COMMONWEALTH PASSED
UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL. TO RESIDENTS OF MASSACHUSETTS:
NO SALE OF THE SECURITIES WILL BE MADE TO RESIDENTS OF THE STATE OF MASSACHUSETTS WHO ARE UNACCREDITED INVESTORS IF THE AMOUNT
OF SUCH INVESTMENT IN THE SECURITIES WOULD EXCEED THIRTY PERCENT (30%) OF SUCH INVESTOR'S NET WORTH (EXCLUDING PRINCIPAL RESIDENCE,
FURNISHINGS THEREIN AND PERSONAL AUTOMOBILES).

 

FOR RESIDENTS OF MICHIGAN

 

NO
SALE OF THE SECURITIES WILL BE MADE TO RESIDENTS OF THE STATE OF MICHIGAN WHO ARE UNACCREDITED INVESTORS IF THE AMOUNT OF
SUCH INVESTMENT IN THE SECURITIES WOULD EXCEED THIRTY PERCENT (30%) OF SUCH INVESTOR'S NET WORTH.

 

FOR RESIDENTS OF MINNESOTA

 

THESE SECURITIES BEING OFFERED HEREBY HAVE
NOT BEEN REGISTERED UNDER CHAPTER 80A OF THE MINNESOTA SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED
OF EXCEPT PURSUANT TO REGISTRATION, OR AN EXEMPTION THEREFROM.

 

FOR RESIDENTS OF MISSISSIPPI

 

IN MAKING AN INVESTMENT DECISION, INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THIS OFFERING, INCLUDING THE
MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY
AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

 

 

    	 	x	 

     

    

 

FOR RESIDENTS OF MISSOURI

 

NO
SALE OF THE SECURITIES WILL BE MADE TO RESIDENTS OF THE STATE OF MISSOURI WHO ARE UNACCREDITED INVESTORS IF THE AMOUNT OF
SUCH INVESTMENT IN THE SECURITIES WOULD EXCEED TWENTY PERCENT (20%) OF SUCH INVESTOR'S NET WORTH (EXCLUDING PRINCIPAL RESIDENCE,
FURNISHINGS THEREIN AND PERSONAL AUTOMOBILES).

 

FOR RESIDENTS OF MONTANA

 

IN ADDITION TO THE INVESTOR SUITABILITY
STANDARDS THAT ARE OTHERWISE APPLICABLE, ANY INVESTOR WHO IS A MONTANA RESIDENT MUST HAVE A NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS
AND AUTOMOBILES) IN EXCESS OF FIVE (5) TIMES THE AGGREGATE AMOUNT INVESTED BY SUCH INVESTOR IN THE Common Stock.

 

FOR RESIDENTS OF NEBRASKA

 

IF AN INVESTOR ACCEPTS AN OFFER TO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER CHAPTER 15 OF THE NEBRASKA SECURITIES LAW AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED, OR RESOLD
EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

FOR RESIDENTS OF NEVADA

 

IF ANY INVESTOR ACCEPTS ANY OFFER TO PURCHASE
THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION EXEMPT
FROM REGISTRATION UNDER SECTION 49:3-60(B) OF THE NEVADA SECURITIES LAW. THE INVESTOR IS HEREBY ADVISED THAT THE ATTORNEY GENERAL
OF THE STATE OF NEVADA HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING AND THE FILING OF THE OFFERING WITH THE BUREAU
OF SECURITIES DOES NOT CONSTITUTE APPROVAL OF THE ISSUE, OR SALE THEREOF, BY THE BUREAU OF SECURITIES OR THE DEPARTMENT OF LAW
AND PUBLIC SAFETY OF THE STATE OF NEVADA. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL. NEVADA ALLOWS THE SALE OF SECURITIES
TO 25 OR FEWER PURCHASERS IN THE STATE WITHOUT REGISTRATION. HOWEVER, CERTAIN CONDITIONS APPLY, I.E., THERE CAN BE NO GENERAL ADVERTISING
OR SOLICITATION AND COMMISSIONS ARE LIMITED TO LICENSED BROKER-DEALERS. THIS EXEMPTION IS GENERALLY USED WHERE THE PROSPECTIVE
INVESTOR IS ALREADY KNOWN AND HAS A PRE-EXISTING RELATIONSHIP WITH THE COMPANY. (SEE NRS 90.530.11.)

 

FOR RESIDENTS OF NEW HAMPSHIRE

 

NEITHER THE FACT THAT A REGISTRATION STATEMENT
OR AN APPLICATION FOR LICENSE HAS BEEN FILED UNDER CHAPTER 421-B OF THE NEW HAMPSHIRE REVISED STATUTES (THE “RSA”)
WITH THE STATE OF NEW HAMPSHIRE NOR THE FACT THAT A SECURITY IS EFFECTIVELY REGISTERED OR A PERSON IS LICENSED IN THE STATE OF
NEW HAMPSHIRE CONSTITUTES A FINDING BY THE SECRETARY OF STATE OF NEW HAMPSHIRE THAT ANY DOCUMENT FILED UNDER RSA 421-B IS TRUE,
COMPLETE, AND NOT MISLEADING. NEITHER ANY SUCH FACT NOR THE FACT THAT AN EXEMPTION OR AN EXCEPTION IS AVAILABLE FOR A SECURITY
OR A TRANSACTION MEANS THAT THE SECRETARY OF STATE OF NEW HAMPSHIRE HAS PASSED IN ANY WAY UPON THE MERITS OR QUALIFICATIONS OF,
OR RECOMMENDED, OR GIVEN APPROVAL TO, ANY PERSON, SECURITY, OR TRANSACTION. IT IS UNLAWFUL TO MAKE, OR CAUSE TO BE MADE, TO ANY
PROSPECTIVE PURCHASER, CUSTOMER, OR CLIENT ANY REPRESENTATION INCONSISTENT WITH THE PROVISIONS OF THIS PARAGRAPH.

 

 

 

    	 	xi	 

     

    

 

FOR RESIDENTS OF NEW JERSEY

 

IF THE INVESTOR IS A NEW JERSEY RESIDENT
AND THE INVESTOR ACCEPT AN OFFER TO PURCHASE THESE SECURITIES PURSUANT TO THIS MEMORANDUM, THE INVESTOR IS HEREBY ADVISED THAT
THIS MEMORANDUM HAS NOT BEEN FILED WITH OR REVIEWED BY THE ATTORNEY GENERAL OF THE STATE OF NEW JERSEY PRIOR TO ITS ISSUANCE AND
USE. THE ATTORNEY GENERAL OF THE STATE OF NEW JERSEY HAS NOT PASSED ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY REPRESENTATION
TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF NEW MEXICO

 

IN MAKING AN INVESTMENT DECISION, INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISK INVOLVED. THESE SECURITIES
HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES
HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

FOR RESIDENTS OF NEW YORK

 

THIS PRIVATE OFFERING MEMORANDUM HAS NOT
BEEN REVIEWED BY THE ATTORNEY GENERAL PRIOR TO ITS ISSUANCE AND USE. THE ATTORNEY GENERAL OF THE STATE OF NEW YORK HAS NOT PASSED
ON OR ENDORSED THE MERITS OF THIS OFFERING. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

THIS PRIVATE OFFERING MEMORANDUM DOES NOT
CONTAIN AN UNTRUE STATEMENT OF A MATERIAL FACT OR OMIT TO STATE A MATERIAL FACT NECESSARY TO MAKE THE STATEMENTS MADE IN LIGHT
OF THE CIRCUMSTANCES UNDER WHICH THEY ARE MADE, NOT MISLEADING. IT CONTAINS A FAIR SUMMARY OF THE MATERIAL TERMS OF DOCUMENTS PURPORTED
TO BE SUMMARIZED HEREIN.

 

IF AN INVESTOR ACCEPTS AN OFFER TO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER SECTION 107.03(2) OF THE NEW YORK SECURITIES LAW AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED,
OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

FOR RESIDENTS OF NORTH CAROLINA

 

IN MAKING AN INVESTMENT DECISION, INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THE OFFERING, INCLUDING MERITS
AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY.
FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED ACCURACY OR DETERMINED ADEQUACY OF THIS DOCUMENT. REPRESENTATION TO THE
CONTRARY IS UNLAWFUL. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR
AN INDEFINITE PERIOD OF TIME.

 

FOR RESIDENTS OF NORTH DAKOTA

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE SECURITIES COMMISSIONER OF THE STATE OF NORTH DAKOTA NOR HAS THE COMMISSIONER PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

 

 

    	 	xii	 

     

    

 

FOR RESIDENTS OF OKLAHOMA

 

THESE SECURITIES ARE OFFERED FOR SALE IN
THE STATE OF OKLAHOMA IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION FOR PRIVATE OFFERINGS. ALTHOUGH A PRIOR FILING OF THIS MEMORANDUM
AND THE INFORMATION HAS BEEN MADE WITH THE OKLAHOMA SECURITIES COMMISSION, SUCH FILING IS PERMISSIVE ONLY AND DOES NOT CONSTITUTE
AN APPROVAL, RECOMMENDATION OR ENDORSEMENT, AND IN NO SENSE IS TO BE REPRESENTED AS AN INDICATION OF THE INVESTMENT MERIT OF SUCH
SECURITIES. ANY SUCH REPRESENTATION IS UNLAWFUL.

 

FOR RESIDENTS OF OREGON

 

(A) THE SECURITIES OFFERED ARE REGISTERED
WITH THE DIRECTOR OF THE DEPARTMENT OF CONSUMER AND BUSINESS SERVICES FOR THE STATE OF OREGON UNDER PROVISIONS OF OAR 441-65-060
THROUGH 441-65-230. THE DIRECTOR REVIEWED THE REGISTRATION STATEMENT ONLY BRIEFLY AND HAS NOT REVIEWED THIS DOCUMENT. IN DECIDING
WHETHER OR NOT TO INVEST IN THESE SECURITIES, THE INVESTOR SHOULD RELY ON YOUR OWN EXAMINATION OF THE COMPANY ISSUING THE SECURITIES
AND THE TERMS OF THE OFFERING INCLUDING THE MERITS AND RISKS INVOLVED.

                      
 

(B) IN MAKING AN INVESTMENT DECISION INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THE OFFERING, INCLUDING THE
MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY
AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE
AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO REGISTRATION
OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR
AN INDEFINITE PERIOD OF TIME.

                      
 

(C) IN DECIDING WHETHER OR NOT TO INVEST
IN THE SECURITIES OFFERED, THE INVESTOR SHOULD RELY ON YOUR OWN EXAMINATION OF THE COMPANY ISSUING THE SECURITIES AND THE TERMS
OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY ANY FEDERAL
OR STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY. ALSO, NO SUCH AGENCY HAS DETERMINED IF THIS DOCUMENT IS TRUTHFUL
OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

                      
 

YOU WILL NOT BE ABLE TO TRANSFER OR RESELL
THESE SECURITIES EXCEPT PURSUANT TO REGISTRATION UNDER THE FEDERAL SECURITIES ACT OF 1933 OR AN EXEMPTION FROM REGISTRATION IF
AVAILABLE. CONSEQUENTLY, THE INVESTOR MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
TIME.

 

FOR RESIDENTS OF PENNSYLVANIA

 

PURSUANT
TO SECTION 207 OF THE PENNSYLVANIA SECURITIES ACT OF 197, EACH PERSON WHO ACCEPTS THIS OFFER TO PURCHASE SECURITIES EXEMPT
FROM REGISTRATION BY SECTION 203 OF THE PENNSYLVANIA SECURITIES ACT OF 192 DIRECTLY FROM THE COMPANY OR ITS AFFILIATES WILL HAVE
THE RIGHT TO WITHDRAW HIS ACCEPTANCE WITHOUT INCURRING ANY LIABILITY TO THE SELLER, SELLING AGENTS OR ANY OTHER PERSON, WITHIN
TWO (2) BUSINESS DAYS FROM THE DATE OF RECEIPT BY THE ISSUER OF HIS WRITTEN BINDING CONTRACT OF PURCHASE, OR IN THE CASE OF A TRANSACTION
IN WHICH THERE IS NO BINDING CONTRACT OR PURCHASE, WITHIN TWO (2) BUSINESS DAYS AFTER HE MAKES THE INITIAL PAYMENT FOR THE SECURITIES
BEING OFFERED. TO ACCOMPLISH THIS WITHDRAWAL, A SUBSCRIBER NEED ONLY SEND A LETTER OR TELEGRAM TO THE ISSUER AT THE ADDRESS SET
FORTH IN THE TEXT OF THE OFFERING LITERATURE, INDICATING HIS OR HER INTENTION TO WITHDRAW. SUCH LETTER OR TELEGRAM SHOULD BE SENT
AND POSTMARKED PRIOR TO THE END OF THE AFOREMENTIONED SECOND BUSINESS DAY. IT IS PRUDENT TO SEND SUCH LETTER BY CERTIFIED MAIL,
RETURN RECEIPT REQUESTED, TO ENSURE THAT IT IS RECEIVED AND TO EVIDENCE THE TIME WHEN IT WAS MAILED. IF THE REQUEST IS MADE ORALLY
IN PERSON OR BY TELEPHONE TO THE ISSUER AT THE NUMBER LISTED IN THE TEXT OF THE OFFERING LITERATURE, A WRITTEN CONFIRMATION THAT
THE REQUEST HAS BEEN RECEIVED SHOULD BE REQUESTED.

 

 

 

    	 	xiii	 

     

    

 

FOR RESIDENTS OF PUERTO RICO

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE OFFICE OF THE COMMISSIONER OF FINANCIAL INSTITUTIONS OF THE COMMONWEALTH OF PUERTO RICO NOR HAS THE COMMISSIONER
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF RHODE ISLAND

 

THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE DEPARTMENT OF BUSINESS REGULATION OF THE STATE OF RHODE ISLAND NOR HAS THE DIRECTOR PASSED UPON THE ACCURACY
OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

FOR RESIDENTS OF SOUTH CAROLINA

 

THESE
SECURITIES ARE OFFERED PURSUANT TO A CLAIM OF EXEMPTION UNDER THE SOUTH CAROLINA UNIFORM SECURITIES ACT. A REGISTRATION
STATEMENT RELATING TO THE SECURITIES HAS NOT BEEN FILED WITH THE SOUTH CAROLINA SECURITIES COMMISSIONER. THE COMMISSIONER DOES
NOT RECOMMEND OR ENDORSE THE PURCHASE OF ANY SECURITIES, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF THIS PRIVATE PLACEMENT
MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

FOR RESIDENTS OF SOUTH DAKOTA

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER CHAPTER 4A OF THE SOUTH DAKOTA SECURITIES LAWS AND MAY NOT
BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF FOR VALUE EXCEPT PURSUANT TO REGISTRATION, EXEMPTION THEREFROM OF OPERATION OF LAW.
EACH SOUTH DAKOTA RESIDENT PURCHASING ONE OR MORE WHOLE OR FRACTIONAL SECURITIES MUST WARRANT THAT HE HAS EITHER (1) A MINIMUM
NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES) OF $30,000 AND A MINIMUM ANNUAL GROSS INCOME OF $30,000 OR (2) A MINIMUM
NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES) OF $75,000. ADDITIONALLY, EACH INVESTOR WHO IS NOT AN ACCREDITED INVESTOR
OR WHO IS AN ACCREDITED INVESTOR SOLELY BY REASON OF HIS NET WORTH, INCOME OR AMOUNT OF INVESTMENT, SHALL NOT MAKE AN INVESTMENT
IN THE PROGRAM IN EXCESS OF TWENTY PERCENT (20%) OF HIS NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS AND AUTOMOBILES).

 

FOR RESIDENTS OF TENNESSEE

 

IN MAKING AN INVESTMENT DECISION INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE
SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING
AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS
A CRIMINAL OFFENSE.

 

THESE SECURITIES ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY
MAY BE REQUIRED TO BEAR THE FINANCIAL RISK OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

 

 

 

    	 	xiv	 

     

    

 

FOR RESIDENTS OF TEXAS

 

EACH
PURCHASER OF THESE SECURITIES MUST BEAR THE ECONOMIC RISK OF THE INVESTMENT OF AN INDEFINITE PERIOD OF TIME BECAUSE THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE APPLICABLE SECURITIES LAWS AND THEREFORE CANNOT BE SOLD UNLESS THEY ARE SUBSEQUENTLY
REGISTERED UNDER SUCH SECURITIES LAWS OR AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.

 

POTENTIAL
PURCHASERS SHOULD BE AWARE THAT A LEGEND RECITING THE RESTRICTIONS OR TRANSFERABILITY WILL BE PLACED ON THE SECURITY, AND
THAT THEY WILL BE ASKED TO SIGN A WRITTEN AGREEMENT THAT THE SECURITIES WILL NOT BE SOLD WITHOUT REGISTRATION UNDER APPLICABLE
SECURITIES LAWS OR EXEMPTIONS THEREFROM.

 

FOR RESIDENTS OF UTAH

 

THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UTAH UNIFORM SECURITIES ACT AND THEREFORE CANNOT BE RESOLD UNLESS REGISTERED
UNDER SUCH ACT OR EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.

 

FOR RESIDENTS OF VERMONT

 

(I) INVESTMENT IN THESE SECURITIES INVOLVES
SIGNIFICANT RISKS AND IS SUITABLE ONLY FOR PERSONS WHO HAVE NO NEED FOR IMMEDIATE LIQUIDITY IN THEIR INVESTMENT AND WHO CAN BEAR
THE ECONOMIC RISK OF A LOSS OF THEIR ENTIRE INVESTMENT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL
RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

 

(II) IN MAKING AN INVESTMENT DECISION
INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING INCLUDING THE MERITS AND RISKS INVOLVED.
THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE,
THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.

 

(III) THESE SECURITIES ARE SUBJECT
TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT
OF 1933 AND THE VERMONT SECURITIES ACT, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

 

FOR RESIDENTS OF VIRGINIA

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
(OR OTHER DOCUMENT) HAVE BEEN ISSUED PURSUANT TO A CLAIM OF EXEMPTION FROM THE REGISTRATION OR QUALIFICATION PROVISIONS OF FEDERAL
AND STATE SECURITIES LAWS AND SHALL NOT BE SOLD OR TRANSFERRED WITHOUT COMPLIANCE WITH THE REGISTRATION OF QUALIFICATION PROVISIONS
OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR APPLICABLE EXEMPTIONS THEREFROM.

 

FOR RESIDENTS OF WASHINGTON

 

THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND THE SECURITIES ACT OF WASHINGTON CHAPTER 21.20
RCW, SHALL HAVE THE STATUS OF RESTRICTED SECURITIES AND CANNOT BE RESOLD WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933
AND THE SECURITIES ACT OF WASHINGTON OR AN EXEMPTION THEREFROM.

 

 

 

    	 	xv	 

     

    

 

FOR RESIDENTS OF WEST VIRGINIA

 

IF AN INVESTOR ACCEPTS AN OFFER TO PURCHASE
ANY OF THE SECURITIES, THE INVESTOR IS HEREBY ADVISED THE SECURITIES WILL BE SOLD TO AND ACQUIRED BY IT/HIM/HER IN A TRANSACTION
EXEMPT FROM REGISTRATION UNDER SECTION 15.06(B)(9) OF THE WEST VIRGINIA SECURITIES LAW AND MAY NOT BE RE-OFFERED FOR SALE, TRANSFERRED,
OR RESOLD EXCEPT IN COMPLIANCE WITH SUCH ACT AND APPLICABLE RULES PROMULGATED THEREUNDER.

 

FOR RESIDENTS OF WISCONSIN

 

IN ADDITION TO THE INVESTOR SUITABILITY
STANDARDS THAT ARE OTHERWISE APPLICABLE, ANY INVESTOR WHO IS A WISCONSIN RESIDENT MUST HAVE A NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS
AND AUTOMOBILES) IN EXCESS OF THREE AND ONE-THIRD (3 1/3)TIMES THE AGGREGATE AMOUNT INVESTED BY SUCH INVESTOR IN THE Common Stock
OFFERED HEREIN.

 

FOR RESIDENTS OF WYOMING

 

ALL WYOMING RESIDENTS WHO SUBSCRIBE TO
PURCHASE Common Stock OFFERED BY THE COMPANY MUST SATISFY THE FOLLOWING MINIMUM FINANCIAL SUITABILITY REQUIREMENTS IN ORDER TO
PURCHASE Common Stock:

 

(1) A NET WORTH (EXCLUSIVE OF HOME, FURNISHINGS
AND AUTOMOBILES) OF TWO HUNDRED FIFTY THOUSAND DOLLARS ($250,000 ); AND

 

(2) THE PURCHASE PRICE OF Common Stock
SUBSCRIBED FOR MAY NOT EXCEED TWENTY PERCENT (20%) OF THE NET WORTH OF THE SUBSCRIBER; AND

 

(3) "TAXABLE INCOME" AS DEFINED
IN SECTION 63 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, DURING THE LAST TAX YEAR AND ESTIMATED "TAXABLE INCOME"
DURING THE CURRENT TAX YEAR SUBJECT TO A FEDERAL INCOME TAX RATE OF NOT LESS THAN THIRTY-THREE PERCENT (33%).

 

IN ORDER TO VERIFY THE FOREGOING, ALL SUBSCRIBERS
WHO ARE WYOMING RESIDENTS WILL BE REQUIRED TO REPRESENT IN THE SUBSCRIPTION AGREEMENT THAT THEY MEET THESE WYOMING SPECIAL INVESTOR
SUITABILITY REQUIREMENTS.

 

FOR NON-U.S. RESIDENTS

 

NO ACTION HAS BEEN OR WILL BE TAKEN IN
ANY JURISDICTION OUTSIDE THE INTERESTED STATES OF AMERICA THAT WOULD PERMIT AN OFFERING OF THESE SECURITIES, OR POSSESSION OR DISTRIBUTION
OF OFFERING MATERIAL IN CONNECTION WITH THE ISSUE OF THESE SECURITIES, IN ANY COUNTRY OR JURISDICTION WHERE ACTION FOR THAT PURPOSE
IS REQUIRED. IT IS THE RESPONSIBILITY OF ANY PERSON WISHING TO PURCHASE THESE SECURITIES TO SATISFY HIMSELF, HERSELF, OR ITSELF
AS TO FULL OBSERVANCE OF THE LAWS OF ANY RELEVANT TERRITORY OUTSIDE THE UNITED STATES OF AMERICA IN CONNECTION WITH ANY SUCH PURCHASE,
INCLUDING OBTAINING ANY REQUIRED GOVERNMENTAL OR OTHER CONSENTS OR OBSERVING ANY OTHER APPLICABLE FORMALITIES.

 

 

 

 

    	 	xvi	 

     

    

 

THE PURCHASE OF THE UNITS CONSISTING
OF ONE SHARE OF COMMON STOCK AND THE RIGHT TO PURCHASE A SHARE OF COMMON STOCK ENTAILS A NUMBER OF VERY SIGNIFICANT RISKS. SEE
“RISK FACTORS” AND “IMPORTANT CONSIDERATIONS”. BECAUSE OF THESE RISKS, THE INVESTOR SHOULD INVEST YOUR
FUNDS ONLY IF THE INVESTOR IS ABLE TO BEAR THE FULL RISK, AND WITHSTAND THE TOTAL LOSS, OF YOUR ENTIRE INVESTMENT.

 

The Investor is hereby to rely only on
the information contained in this Memorandum and the information incorporated by reference herein. Such information is accurate
only as of the date on the front cover of this Memorandum or, with respect to exhibits which have been incorporated by reference,
as of the date specified therein. the Company’s business, financial condition and prospects may have changed since such date.
No person has been authorized to provide the Investor with different or additional information. the Company do not intend to update
or otherwise revise this Memorandum following its distribution, and recipients of this Memorandum should not expect the Company
to do so. Prospective investors are urged to conduct an independent investigation and evaluation of the Company and the proposed
transaction.

 

The minimum Common Stock purchase is $25,000
which consist of a Share of Common Stock of Odyssey Group International, Inc. and a right to purchase a Share of Common Stock of
Odyssey Group International, Inc., although the Chief Executive Officer of the Company may accept smaller subscriptions in its
sole discretion.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	xvii	 

     

    

 

NOTICE TO ALL PURCHASERS

 

THE OFFER AND SALE OF OF UNITS CONSISTING
OF A SHARE OF COMMON STOCK AND A RIGHT TO PURCHASE A SHARE OF COMMON STOCK HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAS THE SEC OR ANY OTHER REGULATORY AUTHORITY PASSED UPON THE ACCURACY
OR ADEQUACY OF THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

IN MAKING AN INVESTMENT DECISION, INVESTORS
MUST RELY ON THEIR OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THIS OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THE
COMPANY’S COMMON STOCK HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY.

 

THE UNITS CONSISTING
OF A SHARE OF COMMON STOCK AND A RIGHT TO PURCHASE A SHARE OF COMMON STOCK IS SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE
AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SUBSCRIPTION AGREEMENT AND THE SECURITIES ACT, AND OTHER APPLICABLE
SECURITIES LAWS. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE
PERIOD OF TIME AND MUST BE ABLE TO WITHSTAND A TOTAL LOSS OF THEIR INVESTMENT.

 

WHO MAY INVEST

 

The Securities offered hereby have not
been registered under the Securities Act or the securities laws of any jurisdiction and are being offered and sold in reliance
on exemptions from the registration requirements of the Securities Act and such laws. The Securities are subject to restrictions
on transferability and resale and may not be transferred or resold except as permitted under the Securities Act and such laws pursuant
to registration or exemption therefrom. Accordingly, distribution of this Memorandum is strictly limited to persons who meet the
requirements and make the representations set forth below. The Company, in its sole discretion, reserves the right to declare any
prospective Investor ineligible to purchase the Common Stocks for any other reason or for no reason.

 

In making an investment decision, the Investor
must rely on your own examination of the Company, and the persons or entities creating the Shares that the Company will invest
in or lend to and the terms of the Offering, including the merits and risks involved. The Common Stocks are speculative, involve
a significant risk, and are suitable only for persons of substantial financial means who have no need for liquidity in this investment.
The Common Stocks will be sold only to prospective investors who:

 

		(1)	purchase a minimum of $25,000 which consist of a Share of Common Stock of Odyssey Group International,
Inc. and a right to purchase a Share of Common Stock of Odyssey Group International, Inc., unless the Company’s Chief Executive
Officer, in its sole discretion, waives the minimum purchase requirement;

 

		(2)	represent in writing that they are Accredited Investors; and

 

		(3)	satisfy the Investor Suitability Requirements established by the Company and as may be required
under federal or state law.

 

 

 

    	 	1	 

     

    

 

Each prospective Investor must represent
in writing that the Investor meets, among others, ALL of the following requirements:

 

		(a)	The Investor has received, read and fully understands this Memorandum, the Investor is basing the
Investor’s decision to invest only on this Memorandum, the Investor has relied only on the information contained in this
Memorandum, and the Investor has not relied upon any representations made by any other person or other means;

 

		(b)	The Investor understands that an investment in the Common Stocks involves substantial risks and
the Investor is fully cognizant of, and understands, all of the Risk Factors relating to a purchase of the Common Stocks, including,
without limitation, those risks set forth below in the section entitled “RISK FACTORS”;

 

		(c)	The Investor’s overall commitment to investments that are not readily marketable or redeemable
is not disproportionate to his individual net worth, and the Investor’s investment in the Common Stocks will not cause such
overall commitment to become excessive;

 

		(d)	The Investor has adequate means of providing for the Investor’s financial requirements, both
current and anticipated, and has no need for liquidity in this investment;

 

		(e)	The Investor can bear, and is willing to accept, the economic risk of losing the Investor’s
entire investment in the Common Stocks;

 

		(f)	The Investor is acquiring the Common Stocks for the Investor’s own account and for investment
purposes only and has no present intention, agreement, or arrangement for the distribution, transfer, assignment, resale, or subdivision
of the Common Stocks; and

 

		(g)	The Investor is an Accredited Investor.

 

A person or entity that meets one of the following tests will
qualify as an Accredited Investor:

 

		(i)	The prospective Investor is a natural person who had individual income in excess of Two Hundred
Thousand Dollars ($200,000) in each of the two most recent years, or joint income with that person’s spouse in excess of
Three Hundred Thousand Dollars ($300,000) in each of these years, and has a reasonable expectation of reaching the same income
level in the current year; or

 

		(ii)	The prospective Investor is a natural person whose individual net worth (as defined below), or
joint net worth with that person’s spouse, excluding the value of the primary residence, exceeds One Million Dollars ($1,000,000)
at the time of purchase of the Common Stocks; or

 

		(iii)	The prospective Investor is an organization described under Section 501(c)(3) of the Internal Revenue
Code, a corporation, Massachusetts or similar business trust or a partnership, not formed for the specific purpose of acquiring
the Common Stocks, with total assets in excess of Five Million Dollars ($5,000,000); or

 

		(iv)	The prospective Investor is an entity in which each of the equity owners is an Accredited Investor
(as defined in subparagraphs (i) and (ii) above); or

 

		(v)	The prospective Investor is a trust with total assets in excess of Five Million Dollars ($5,000,000),
not formed for the specific purpose of acquiring the Common Stocks, whose purchase is directed by a “sophisticated person”
as defined in Rule 506(b)(2)(ii) of Regulation D under the Act; or is a revocable trust whose settlor-trustees are all Accredited
Investors; or

 

		(vi)	The prospective Investor is an employee benefit plan within the meaning of the U.S. Federal Employment
Rights and Income Security Act, U.S.C. Title 29, Section 18, or ERISA, in which the investment decision is made by a plan fiduciary
(as defined in Section 3(21) of ERISA) which is either a bank, savings-and-loan association, insurance company, or registered investment
adviser; or the employee benefit plan has total assets in excess of Five Million Dollars ($5,000,000); or it is a self-directed
plan in which investment decisions are made solely by persons who are Accredited Investors.

 

 

 

    	 	2	 

     

    

 

In the case of fiduciary accounts, the
net worth and/or income suitability requirements must be satisfied by the beneficiary of the account, or by the fiduciary, if the
fiduciary directly or indirectly provides funds for the purchase of the Common Stocks.

 

Representations with respect to the foregoing
and certain other matters will be made by each prospective Investor in the Subscription Agreement. Prospective investors who are
unable or unwilling to make the foregoing representations may not purchase the Common Stocks. The Company will rely on the accuracy
of such representations and may require additional evidence that the prospective Investor satisfies the applicable standards at
any time prior to acceptance. Prospective investors are not obligated to supply any information so requested by the Company, but
the Company may reject a Subscription Agreement from any prospective Investor who fails to supply any information so requested.

 

The Investor Suitability Requirements stated
above represent minimum suitability requirements, as established by the Company for prospective investors. However, satisfaction
of such requirements will not necessarily mean that the Common Stocks are a suitable investment for the prospective Investor, or
that the Company will accept the prospective Investor’s Subscription Agreement. Furthermore, the Company’s Chief Executive
Officer, as appropriate, may modify such requirements, at its sole discretion from time to time, and any such modification may
increase the suitability requirements for certain prospective Investor, except that the Company’s Chief Executive Officer
may not relax the Minimum Offering amount.

 

Bad
Actor Disqualification. Certain investors who would own Twenty Percent (20%) or more of the Common Stocks as a result
of their subscriptions may be asked to execute and deliver a Bad Actor Addendum and Irrevocable Proxy as determined by the Company.
Execution and delivery of a Bad Actor Addendum and Irrevocable Proxy shall be a condition to such investors’ subscriptions
for Common Stocks.

 

THE SECURITIES MAY NOT BE A SUITABLE
INVESTMENT FOR A QUALIFIED PLAN, AN IRA OR OTHER TAX-EXEMPT ENTITY. THEREFORE, THIS MEMORANDUM DOES NOT DISCUSS RISKS THAT MAY
BE ASSOCIATED WITH AN INVESTMENT IN THE COMMON STOCK BY A QUALIFIED PLAN, AN IRA OR OTHER TAX-EXEMPT ENTITY.

 

Also, each investor must represent in writing
that the investor meets, among other requirements, the following additional investment requirements:

 

THE INVESTOR UNDERSTANDS THAT THE TAX
CONSEQUENCES OF AN INVESTMENT IN THE SECURITIES ARE COMPLEX AND VARY WITH THE FACTS AND CIRCUMSTANCES OF EACH INDIVIDUAL INVESTOR.

 

This Memorandum contains summaries of certain
other documents, which summaries are believed to be accurate, but reference is hereby made to the full text of the actual documents
for complete information concerning the rights and obligations of the parties thereto. Such information necessarily incorporates
significant assumptions, as well as factual matters. All documents relating to this Offering and related documents and agreements,
if readily available to the Company, will be made available to a prospective investor or its representatives upon request to the
Company. During the course of this Offering and prior to sale, each prospective investor is invited to ask questions of and obtain
additional information from the Company concerning the terms and conditions of this Offering, the Company, the Common Stocks and
any other relevant matters, including, but not limited to, additional information necessary or desirable to verify the accuracy
of the information set forth in this Memorandum. The Company will provide the information to the extent it possesses such information
or can obtain it without unreasonable effort or expense. No person has been authorized by the Company to make any representations
or warranties or to furnish any information with respect to or on behalf of the Company or the Common Stocks other than as set
forth in this Memorandum.

 

IF THE INVESTOR DOES NOT MEET THE REQUIREMENTS
DESCRIBED ABOVE, DO NOT READ FURTHER AND IMMEDIATELY RETURN THIS MEMORANDUM TO THE COMPANY. IN THE EVENT THE INVESTOR DO NOT MEET
SUCH REQUIREMENTS, THIS MEMORANDUM DOES NOT CONSTITUTE AN OFFER TO SELL COMMON STOCK TO YOU.

 

 

 

    	 	3	 

     

    

 

Restrictions Imposed by the USA PATRIOT Act and Related Acts

 

The Common Stocks may not be offered, sold,
transferred or delivered, directly or indirectly, to any “Unacceptable Investor.” “Unacceptable Investor”
means any person or any subsidiary, affiliate, owner, shareholder, partner, member, indemnitor, guarantor or related person or
entity which:

 

	 	(a)	is a Sanctioned Person (as defined below);

 

		(b)	has more than Fifteen (15%) of its assets in Sanctioned Countries (as defined below); or

 

(c)          
derives more than Fifteen (15%) of its operating income from investments in, or transactions with Sanctioned Persons or
Sanctioned Countries.

 

For purposes of the foregoing, a “Sanctioned Person”
means:

 

(a)          
a person named on the list of “specially designated nationals” or “blocked persons” maintained by
the U.S. Office of Foreign Assets Control (“OFAC”) at http://www.treasury.gov/resource-center/sanctions/SDN-
List/Pages/default.aspx, or as otherwise published from time to time, or

 

(b)           
 (i) an agency of the government of a Sanctioned Country, (ii) an organization controlled by a Sanctioned Country, or (iii)
a person resident in a Sanctioned Country, to the extent subject to a sanctions program administered by OFAC.

 

A
“Sanctioned Country” shall mean a country subject to a sanctions program identified on the list maintained by OFAC
and available at http://www.treasury.gov/resource-center/sanctions/Programs/Pages/Programs.aspx, or as otherwise published
from time to time.

 

SUBSCRIPTION
PROCEDURE AND CLOSINGS

 

Investors who would like to subscribe for
the Common Stocks must carefully read this Memorandum, including all exhibits. Then, Investors must complete, execute, and deliver
the Subscription Agreement, a form of which is attached hereto as Exhibit A, along with any additional documents
necessary for closing as provided by the Company.

 

These documents should be emailed, mailed
or delivered to the Company at the address set forth in the Common Stock Purchase Agreement.

 

The Company will review the signed Common
Stock Purchase Agreement and attempt to verify the Investor’s investment qualification. The Company will have the right,
in the Odyssy’s sole discretion, to accept or reject any prospective Investor’s subscription. The Company will notify
each prospective Investor in writing whether its subscription has been accepted or rejected.

 

 

 

 

 

 

 

 

 

 

    	 	4	 

     

    

 

Offering

 

The Company is offering (the “Offering”)
up to Three Million one Hundred Twenty-Five Thousand (3,125,000) Units which shall consist of One (1) Share of the Company’s
Common Stock (the “Common Stocks” or each “Common Stock”) to be priced at a twenty percent (20%) discount
to market priced on the close of trading on Tuesday, March 2, 2021. The price will reflect the highest price traded on that day.
The Company has set a floor of Eighty Cents ($0.80) per share and a ceiling and the right to purchase One (1) share of Common Stock
at a price of Two Dollars ($2.00). The right to purchase the Common Stock shall exist from the acceptance date of the individual
subscription to the one year anniversary of the acceptance of the subscription.

 

This Offering is being
made on a “No Minimum” basis, meaning no minimum amount of money must be raised for a closing to occur. Upon clearance
of the funds on deposit and approval of the subscription by the Company, the Units consisting of One (1) Share of Common Stock
of the Company and the right to purchase One (1) Share of Common Stock of the Company for a strike price of Two Dollars ($2.00)
per share will be promptly distributed to the investors. There is no guarantee that the Issuer will raise all of the funds necessary
to implement the business plan and your entire investment could be lost. All net proceeds from the sale of the Units being offered
will accrue to the Company. The period of time in which the Issuer will accept subscriptions for up to Three Million one Hundred
Twenty-Five Thousand (3,125,000) Units will begin on the date of this Confidential Private Placement Memorandum (the “Memorandum”)
and will terminate on March 5, 2021, with a one (1) year option to extend at the sole discretion of the Company (the “Offering
Period”).

 

Except for any rescission rights that may
be provided under applicable law, subscriptions may not be canceled, terminated or revoked. The Issuer may accept subscriptions
from persons affiliated with the Issuer’s officers and directors. The Issuer reserves the right to reject any subscription,
in whole or in part, for any reason or for no reason. See “Plan of Distribution.”

 

Closings may take place until the Termination
Date, as may be extended, or shortly thereafter to accommodate a brief period for document review and funding.

 

Offers
and sales of Common Stocks will be made only to “Accredited Investors,” as such term is defined in Rule 501(a) of Regulation
D promulgated under the Securities Act, in an offering intended to be exempt from registration pursuant to Rule 506 of Regulation
D promulgated under the Securities Act. Each prospective investor will be required to submit a questionnaire that will be utilized
and relied upon by the Issuer in evaluating and determining his/her/its suitability and qualification as an investor in this Offering,
and to execute a subscription agreement which will govern the rights of investors in making an investment in the Issuer.

 

Subscription Procedure

 

Each prospective investor in the Securities
will be provided with a subscription package, together with instructions, along with this Private Placement Memorandum (“Memorandum”).
In order to subscribe for Units, a subscriber must deliver the following to the Issuer:

 

		1.	A signed copy of the Common Stock Purchase Agreement in the form included in the subscription
package as Exhibit A.

 

		2.	A signed and completed copy of the Investor Questionnaire in the form included in the subscription
package as Exhibit B.

 

		3.	A completed Anti-Money laundering Information Form included in the subscription package as Exhibit
D.

 

		4.	Either (i) a wire transfer to the account listed on Exhibit C or (ii) a check payable to
Odyssey Group International, Inc., in accordance with the instructions included in the subscription package as Exhibit A
for the total purchase price of the Securities being subscribed for.

 

 

 

 

    	 	5	 

     

    

 

Upon delivery of the signed Subscription
Agreement, the Investor Questionnaire, the Anti-Money laundering Information Form, and the required payment as indicated above,
each subscriber will become bound by the terms of its Common Stock Purchase Agreement and will not be able to revoke its subscription.

 

The
Issuer will furnish each investor whose subscription is accepted with copies of the fully executed Common Stock Purchase Agreement.
The Units purchased pursuant to this Offering will be represented by book entry Shares in the stock register.

 

Suitability Standard for Investors

 

Investment in the Common Stock is suitable
only for persons who can afford to make high risk, non-liquid investments. The Common Stock will not be readily transferable because
of the absence of any established market for the Common Stock and because of the restrictions on transfer imposed by law. Accordingly,
the investor must view the investment in the Common Stock as a long term, illiquid investment.

 

The investor must also satisfy the Company
that the investor is purchasing Common Stocks for investment only and not with a view toward resale or distribution and that the
investor is an “Accredited Investor” as such term is defined in Rule 501 of Regulation D of the Securities Act. The
term Accredited Investor includes: (1) an individual who, either individually or jointly with his or her spouse, has a net worth
(i.e., total assets in excess of total liabilities excluding the personal residence) of at least One Million Dollars ($1,000,000.00)
or whose annual income exceeded Two Hundred Thousand Dollars ($200,000.00) in each of the last Two (2) years, or whose joint income
with his or her spouse was in excess of Three Hundred Thousand Dollars ($300,000.00) in each of those years, and who has a reasonable
expectation of reaching the same income level in the current year; or (2) certain institutional investors; or (3) a corporation,
business, trust or partnership or trust whose investment in the Issuer is directed by a sophisticated person, in each case, not
formed for the specific purpose of acquiring the Company’s Common Stocks and with total assets in excess of Five Million
Dollars ($5,000,000.00); or (4) any entity in which all of the equity owners are in their own right Accredited Investors. The investor
must also demonstrate: (1) that the investor, by virtue of the investor’s knowledge and experience in financial and business
matters, are capable of evaluating the merits and risks of investing in the Issuer; (2) that the investor have the capacity to
protect your own Common Stocks in connection with this Offering; and (3) that the investor is able to bear the risk of the Investor’s
investment in the Issuer.

 

In addition to the foregoing suitability
standards, the investor will be required to represent that the investor have funds adequate to meet your personal needs and contingencies,
that the investor have no need for liquidity of the Investor’s investment in the Issuer, that the purchase of the Common
Stocks is for investment only and not with a view toward sale or distribution thereof, and that no Common Stocks are being acquired
on behalf of a person who could not meet the standards for investment.

 

Plan of Distribution

 

The Issuer intends to offer the Units each
consisting of One (1) share of Common Stock to be priced at a twenty percent (20%) discount to market priced on the close of trading
on Tuesday, March 2, 2021. The price will reflect the highest price traded on that day. The Company has set a floor of Eighty Cents
($0.80) per share and a ceiling and and the right to purchase One (1) Share of Common Stock at a purchase price of Two Dollars
($2.00) per share as described in this Memorandum through its officers who are not being paid any commission for doing so.

The Common Stocks are being offered with
a minimum investment of Twenty-Five Thousand Dollars ($25,000.00) offered in the Memorandum by Odyssey Group International, Inc.
However, at its sole discretion, the Issuer may accept subscriptions for lesser amounts. Further, the Issuer may, in its sole discretion,
reject any subscription offer, in whole or in part, for any reason or no reason.

 

The
Common Stocks to be sold pursuant to this Offering will not be registered and hence, will be deemed to be “restricted securities”
for purposes of the Securities laws. The Company has no plan to register the Common Stocks, and the Issuer is under
no obligation to do so. See “Description of Securities”.

 

 

 

    	 	6	 

     

    

 

OFFERING SUMMARY

 

Prospective investors should read the
following summary together with the more detailed information concerning the Issuer and the Securities being sold in this Offering.
Because this is only a summary, prospective investors should read the rest of this Memorandum before investing, especially the
“Risk Factors”.

 

	Issuer: 	Odyssey Group International, Inc., a Nevada Corporation.
	 	 
	Offering: 	The Issuer is offering a maximum of Three Million one Hundred Twenty-Five Thousand (3,125,000) Units.  Each Unit entitles the Investor to One (1) Share of Common Stock and the right to Purchase a Share of Common Stock at a purchase price of Two Dollars ($2.00) per share for a period of One (1) year after the date of the closing of the transaction issuing the warrant.
	 	 
	Offering Price:	The Company will price the offering at a twenty percent (20%) discount to market priced on the close of trading on Tuesday, March 2, 2021.  The price will reflect the highest price traded on that day.  The Company has set a floor of Eighty Cents ($0.80) per share and a ceiling of One Dollar ($1.00) price per share of restricted common stock (“Shares”).
	 	 
	Minimum Investment:	The minimum investment for an investor is Twenty-Five Thousand Dollars ($25,000.00) of Odyssey Group International, Inc. The Issuer may waive such minimum investment in its sole discretion.
	 	 
	Maximum Investment:	The maximum investment for an investor is Two Million Five Hundred Thousand Dollars ($2,500,000) or Three Million one Hundred Twenty-Five Thousand (3,125,000) Shares of Common Stock of Odyssey Group International, Inc.  
	 	 
	Use of Proceeds:	The Proceeds of this Offering will be used for general corporate purposes as more fully described under “Use of Proceeds.”
	 	 
	Costs of Offering:	The Issuer will pay all of its costs and expenses of the Offering, including attorneys’ fees and fees of its consultants engaged to advise the Issuer in connection with the Offering, costs of complying with federal and state securities laws and regulations, commissions, and other miscellaneous expenses. 
	 	 
	Private Placement:	The Securities offered hereby have not been registered under the Securities Act or the Securities laws of any state and are being offered and sold in reliance on exemptions of the Securities Act and such state laws. These Securities may not be transferred or sold except as permitted under the Securities Act and such state laws pursuant to a registration thereunder or an exemption therefrom. The Common Stocks will be offered and sold solely to “Accredited Investors” (as that term is defined in Rule 501(a) of Regulation D under the Securities Act).
	 	 
	Subscription Documents:	To subscribe, a qualified subscriber must complete, execute and return to the Issuer, the Common Stock Purchase Agreement and Investor Questionnaire (the “Subscription Agreements”) which contain representations, covenants, warranties and undertakings, all of which should be carefully considered by the subscriber before execution. A qualified subscriber should also either deliver a cashier’s check payable to the Issuer or send a wire transfer to the escrow account established for this transaction in an amount equal to the purchase price for the Units subscribed. See “Subscription Procedure and Closing.” 
	 	 
	Acceptance or Rejection of Subscriptions:	Subscription Agreements are not binding until accepted by the Issuer. If the Issuer rejects all or a portion of any subscription, the Issuer will return to the prospective subscriber all, or the appropriate portion, of the amount submitted with such prospective subscriber’s subscription, without interest or deduction. 
	 	 

 

 

 

    	 	7	 

     

    

 

	Offering Termination Date:	The Company will offer the Units through the earliest of (a) the date the Company raises the Maximum Offering Amount; (b) will terminate will terminate on March 5, 2021, with a one (1) year option to extend at the sole discretion of the Company or (c) such earlier date as determined by the Company’s Chief Executive Officer in its sole discretion. 
	 	 
	Common Stock Outstanding	90,570,202 Shares (as of October 31, 2020).
	 	 
	Use Of Proceeds	
        Any proceeds received receive are expected to be used for general
        corporate purposes, capital expenditures, working capital and general and administrative expenses. As the remainder of the proceeds
        are intended to be used for working capital, research and development and operational expenses, some of such proceeds may be used
        from time to time to pay officer and director compensation

        

	 	 
	Risk Factors	Investing In Our Securities Involves A High Degree Of Risk. See “Risk Factors” Beginning On Page 12  And The Other Information Included In This Prospectus For A Discussion Of Factors You Should Carefully Consider Before Deciding To Invest In The Units.
	 	 
	Otcqb Trading Symbol	“ODYY”

 

 

 

THERE CAN BE NO GUARANTEE
THAT THE MEMBERS WILL RECEIVE A RETURN OF ALL OR PART OF THEIR INITIAL CAPITAL CONTRIBUTION OR THAT THEY WILL RECEIVE A RETURN
ON THEIR INVESTMENT.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	8	 

     

    

 

FORWARD-LOOKING
STATEMENTS

 

This Memorandum includes statements
that are, or may be deemed to be, “forward-looking statements,” as defined in the Private Securities Reform Act of
1995. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes,”
“estimates,” “anticipates,” “projects,” “expects,” “intends,” “may,”
“will,” “seeks” or “should” or, in each case, their negative or other variations or comparable
terminology, or in relation to discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking
statements include matters that are not historical facts. They appear in a number of places throughout this Private Placement Memorandum
and include statements regarding Issuer’s current intentions, beliefs or expectations concerning, among other things, the
Issuer’s future plans for the Project, results of operations, financial condition, prospects, growth, strategies and the
markets in which the Issuer intends to operate.

 

By their nature, forward-looking statements
involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.
Forward-looking statements are not an assurance of future performance. The Issuer’s actual results of operations and financial
condition may differ materially from those suggested by the forward-looking statements contained in this document. In addition,
even if the Issuer’s future results of operations and financial condition are consistent with the forward-looking statements
contained in this document, those results or developments may not be indicative of results or developments in subsequent periods.
The information in this Private Placement Memorandum, including, but not limited to, the information under “Risk Factors,”
identifies important factors that could cause such differences (including, but not limited to, a change in overall economic conditions
in the United States, a change in the Issuer’s financial condition, changes in tax law or the interpretation thereof, interest
rate fluctuations and other market conditions, and the effect of new legislation or government directives).

 

Forward-looking statements include,
but are not limited to, information concerning possible or assumed future results of the Issuer’s operations set forth under
the section entitled “Business of the Issuer”. Such statements, estimates and projections reflect various assumptions
by the Issuer concerning anticipated results and are subject to significant business, financing, economic and competitive uncertainties
and contingencies, many of which are beyond the control of the Issuer and are based upon assumptions with respect to future business
decisions that are subject to change. Accordingly, there can be no assurance that such statements, estimates and projections will
be realized or that actual results will not vary considerably from those anticipated, expected or projected. The Issuer, its accountants,
its legal advisers and its agents or affiliates do not make any representations as to the accuracy or completeness of such statements,
estimates and projections, or that any forecasts will be achieved.

 

The Issuer is not obliged to, and does
not intend to, update or revise any forward-looking statements made in this Private Placement Memorandum whether as a result of
new information, future events or otherwise. All subsequent written forward-looking statements attributable to the Issuer, or persons
acting on behalf of the Issuer, are expressly qualified in their entirety by the cautionary statements contained throughout this
Private Placement Memorandum. As a result of these risks, prospective investors of the Common Stocks should not place undue reliance
on these forward-looking statements. Neither the forward-looking statements nor the underlying assumptions have been verified or
audited by any third party.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	9	 

     

    

 

Presentation
of Certain Other Information

 

Market data and certain industry forecasts
used throughout this Memorandum have been obtained from market research, publicly available information, industry publications
and officially prepared materials from government agencies.

 

Industry publications generally state that
the information that they contain has been obtained from sources believed to be reliable but that the accuracy and completeness
of that information is not guaranteed. Similarly, internal surveys, industry forecasts and market research, while believed to be
reliable, have not been independently verified, and the Issuer makes no representation as to the accuracy of that information.

 

Certain monetary amounts in this Private
Placement Memorandum have been subject to rounding adjustments; accordingly, figures shown as totals in certain tables may not
be an arithmetic aggregation of the figures, which precede them.

 

Independent
Evaluation

 

This Memorandum does not purport to be
all-inclusive or to contain all of the information that a prospective investor may desire in evaluating an investment in the Common
Stocks. Prior to the consummation of the offer and sale of any of the Securities described herein, the Issuer will afford prospective
investors an opportunity to ask questions of and receive answers from the Issuer concerning the terms and conditions of the Securities
described herein, the Issuer, or other relevant matters and to obtain additional information to the extent the Issuer possesses
such information or can acquire it without unreasonable effort or expense. Any such questions should be directed to Odyssey Group
International, Inc., 2372 Morse Ave. Irvine, California 92614.

 

No person or entity has been authorized
to give any information or to make representations about the Issuer or the Offering and, if given or made, any such information
or representation by any other person or entity must not be relied upon as having been authorized by the Issuer. Each prospective
investor must conduct and rely on his own evaluation of the Issuer and the terms of the Offering (including the merits and risks
involved) in making an investment decision with respect to the Shares described herein. Investment in the Common Stocks involves
a high degree of risk and is suitable only for investors capable of sustaining a loss of their entire investment. See “Risk
Factors.”

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	10	 

     

    

 

RISK FACTORS

 

An
investment in the Units is highly speculative and involves a high degree of risk. Before making an investment decision,
you should carefully consider the risks described under “Risk Factors” in the applicable prospectus supplement and
the risks described in our most recent Annual Report on Form 10-K for the year ended July 31, 2020, as amended from time to time,
which is incorporated herein by reference, or any updates in our Quarterly Reports on Form 10-Q, together with all of the other
information appearing in or incorporated by reference into this prospectus and any applicable prospectus supplement, in light of
your particular investment objectives and financial circumstances. Our business, financial condition or results of operations could
be materially adversely affected by any of these risks. The trading price of our Securities could decline due to any of these risks,
and you may lose all or part of your investment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

THE OFFERING

 

The Company is offering (the “Offering”)
up to Three Million one Hundred Twenty-Five Thousand (3,125,000) Units each of which entitles the Investor to receive One (1) Share
of Common Stock to be priced at a twenty percent (20%) discount to market priced on the close of trading on Tuesday, March 2, 2021.
The price will reflect the highest price traded on that day. The Company has set a floor of Eighty Cents ($0.80) per share and
a ceiling and the right to purchase One (1) Share of Common Stock at a purchase price per share of Two Dollars ($2.00). This right
to purchase One (1) Share of Common Stock at a purchase price per share of Two Dollars ($2.00) terminates on the One (1) year anniversary
of the closing of the Investors Units.

 

This
Offering is being made on a “No Minimum” basis, meaning no minimum amount of money must be raised for a closing to
occur. Upon clearance of the funds on deposit and approval of the subscription by the Company, the Shares will be promptly distributed
to the investors. There is no guarantee that the Issuer will raise all of the funds necessary to implement the business plan and
your entire investment could be lost. All net proceeds from the sale of the Common Stocks being offered will accrue to the Company.
The period of time in which the Issuer will accept subscriptions for up to Three Million one Hundred Twenty-Five Thousand (3,125,000)
Shares of Common Stocks will begin on the date of this Confidential Private Placement Memorandum (the “Memorandum”)
and will terminate will terminate on March 15, 2021, with a one (1) year option to extend at the sole discretion of the Company
or (c) such earlier date as determined by the Company’s Chief Executive Officer in its sole discretion. (the “Offering
Period”).

 

Except for any rescission rights that may
be provided under applicable law, subscriptions may not be canceled, terminated or revoked. The Issuer may accept subscriptions
from persons affiliated with the Issuer’s officers and directors. The Issuer reserves the right to reject any subscription,
in whole or in part, for any reason or for no reason. See “Plan of Distribution.”

 

Closings may take place until the Termination
Date, as may be extended, or shortly thereafter to accommodate a brief period for document review and funding.

 

Offers
and sales of Common Stocks will be made only to “Accredited Investors,” as such term is defined in Rule 501(a) of Regulation
D promulgated under the Securities Act, in an offering intended to be exempt from registration pursuant to Rule 506 of Regulation
D promulgated under the Securities Act. Each prospective investor will be required to submit a questionnaire that will be utilized
and relied upon by the Issuer in evaluating and determining his/her/its suitability and qualification as an investor in this Offering,
and to execute a subscription agreement which will govern the rights of investors in making an investment in the Issuer.

 

USE OF
PROCEEDS

 

If
all Three Million one Hundred Twenty-Five Thousand (3,125,000) Units are sold, the net proceeds to be received by the Issuer
from the sale of the Common Stocks is estimated to be Two Million Five Hundred Thousand Dollars ($2,500,000). The Use of Proceeds
will be used for general corporate purposes. Odyssey intends to use the net proceeds from the sale of the Securities covered by
this prospectus for general corporate purposes, which may include, but is not limited to, working capital, capital expenditures,
research and development expenditures and acquisitions of new technologies or businesses. The precise amount, use and timing of
the application of such proceeds will depend upon our funding requirements and the availability and cost of other capital.

 

BUSINESS OF THE ISSUER

 

Odyssey
was formed as a publicly held holding company with an emphasis on the development and acquisition of medical products and health
related technologies. We are focused on building and acquiring assets in areas that have an identified technological advantage
and a substantial market opportunity within significant target markets across the globe. Before making an investment decision,
you should carefully consider the business of the Company as described in our most recent Annual Report on Form 10-K for the year
ended July 31, 2020, as amended from time to time, which is incorporated herein by reference, or any updates in our Quarterly Reports
on Form 10-Q, together with all of the other information appearing in or incorporated by reference into this prospectus and any
applicable prospectus supplement, in light of your particular investment objectives and financial circumstances.

 

 

 

    	 	12	 

     

    

 

Corporate Information

 

Odyssey was formed as a Nevada corporation
on March 19, 2014. Our principal executive offices are located at 2372 Morse Ave., Irvine, California 92614. The registration statement
effectuating our initial public offering became effective in July 2015.

 

Currently our shares of Common Stock are
quoted on the Over the Counter Venture (OTCQB) exchange and there is currently very little public market for our Common Stock.

 

Subscription Procedures

 

Investors desiring to purchase Common Stocks
must carefully read this Memorandum (including the exhibits hereto). Then, prospective investors must follow the instructions set
forth in “HOW TO SUBSCRIBE” in this Memorandum.

 

Qualifications of Investors

 

The Common Stocks may be purchased only
by investors who satisfy certain suitability requirements. See “WHO MAY INVEST.”

 

Acceptance of Subscriptions

 

The Company has the right, to be exercised
in its sole discretion, to accept or reject any subscription in whole or in part for a period of fifteen (15) days after receipt
of the subscription. Any subscription not accepted within fifteen (15) days of receipt shall be deemed rejected.

 

Limitation of Offering

 

The offer and sale of the Common Stocks
offered hereby are made in reliance upon exemptions from the Securities Act and state securities laws. Accordingly, distribution
of this Memorandum has been strictly limited to persons satisfying the Investor Suitability Requirements described herein, and
this Memorandum does not constitute an offer to sell or a solicitation of an offer to buy with respect to any person not satisfying
those qualifications.

 

MANAGEMENT

 

Executive Officers and Directors

 

Before making an investment decision,
you should carefully consider the Management of the Company and specifically, the Executive Officers and Directrors of the Company
as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2020, as amended from time to time, which
is incorporated herein by reference, or any updates in our Quarterly Reports on Form 10-Q, together with all of the other information
appearing in or incorporated by reference into this prospectus and any applicable prospectus supplement.

 

Code of Ethics

 

We have adopted a Code of Ethics that applies
to our directors, officers and all employees. It may be obtained free of charge by writing to Odyssey Group International, Inc.,
Attn: Chief Executive Officer, 2372 Morse Ave, Irvine, CA 92614.

 

 

 

    	 	13	 

     

    

 

Board of Directors

 

Our board of directors currently consists
of five (5) members, three (3) of which are independent directors. Our bylaws permit up to twelve (12) members of the board of
directors.

 

Director Independence

 

Under the rules of the national securities
exchanges, a majority of a listed company’s board of directors must be comprised of independent directors, and each member
of a listed company’s audit, compensation, and nominating and corporate governance committees must be independent as well.
Under the same rules, a director will only qualify as an “independent director” if that company’s board of directors
affirmatively determines that such director has no material relationship with that company, either directly or as a partner, shareholder
or officer of an organization that has a relationship with that company.

 

Our board of directors currently consists
of five members. Messrs. Casey, Conroy and Gandolfo are independent directors.

 

In addition, the members of our audit committee
must satisfy the independence criteria set forth in Rule 10A-3 under the Securities Exchange Act of 1934, as amended, or Rule 10A-3.
In order to be considered to be independent for purposes of Rule 10A-3, no member of the audit committee may, other than in his
capacity as a member of the audit committee, the board of directors or any other board committee: (1) accept, directly or indirectly,
any consulting, advisory or other compensatory fee from the company or any of its subsidiaries or (2) be an affiliated person of
the company or any of its subsidiaries.

 

Committees of our Board
of Directors

 

On October 17, 2019, the board of directors
of the Company established audit, compensation and nominating and corporate governance, committees.

 

Audit
Committee. We established an audit committee, which consists of three independent directors. The audit committee's
duties are to recommend to the Company's board of directors, the engagement of independent auditors to audit our financial statements
and to review its accounting and auditing principles. The audit committee reviews the scope, timing and fees for the annual audit
and the results of audit examinations performed by the internal auditors and independent public accountants, including their recommendations
to improve the system of accounting and internal controls. The audit committee is composed exclusively of directors who are, in
the opinion of our board of directors, free from any relationship which would interfere with the exercise of independent judgment
as a committee member and who possess an understanding of financial statements and generally accepted accounting principles.

 

Compensation
Committee. We established a compensation committee, which consists of three independent directors. The compensation
committee responsible for determining executive and director compensation. In considering and determining executive and director
compensation, our compensation committee will be responsible for reviewing compensation that is paid by other similar public companies
to its officers and will take that into consideration in determining the compensation to be paid to the Company’s officers.
The compensation committee determines and approves any non-cash compensation to any employee. We have not and do not intend to
engage consultants in determining or recommending the compensation to our officers or employees.

 

Corporate
Governance and Nominating Committee. We established a corporate governance and nominating committee, which consists
of three independent directors. The nominating committee is a committee of the Company established to support the board of directors
in fulfilling its fiduciary duties to appoint the best-qualified candidates for the board of directors, board president-elect and
CEO positions.

 

 

 

    	 	14	 

     

    

 

Limitation of Liability
and Indemnification Matters

 

Our articles of incorporation contain provisions
that limit the liability of our directors for monetary damages to the fullest extent permitted by Nevada law.

 

Our articles of incorporation and bylaws
authorize our company to provide indemnification to our directors and officers and persons who are or were serving at our request
as a director, officer, manager or trustee of another corporation or of a partnership, limited-liability company, joint venture,
trust or other enterprise to the fullest extent permitted by Nevada law. Our articles of incorporation and bylaws also authorize
our company, by action of our board of directors, to provide indemnification to employees and agents of our company and persons
who are serving or did serve at our request as an employee or agent of another corporation or of a partnership, limited-liability
company, joint venture, trust or other enterprise with the same scope and effect as provided to our directors and officers as described
above.

 

No pending litigation or proceeding involving
a director, officer, employee or other agent of our company currently exists as to which indemnification is being sought. We are
not aware of any threatened litigation that may result in claims for indemnification by any director, officer, employee or other
agent of our company.

 

We anticipate obtaining director and officer
liability insurance with respect to possible director and officer liabilities arising out of certain matters, including matters
arising under the Securities Act.

 

506(e) Disclosure

 

On July 10, 2013, the SEC adopted bad actor
disqualification provisions for Rule 506 of Regulation D under the Act, to implement Section 926 of the Dodd-Frank Wall Street
Reform and Consumer Protection Act. The disqualification and related disclosure provisions appear as paragraphs (d) and (e) of
Rule 506 of Regulation D. Under Rule 506(e), for disqualifying events that occurred before September 23, 2013, issuers may still
rely on a Rule 506, but will have to comply with the disclosure provisions of Rule 506(e). Disqualification will not arise as a
result of disqualifying events that occurred before September 23, 2013, the effective date of the rule amendments. Matters that
existed before the effective date of the rule and would otherwise be disqualifying are, however, required to be disclosed in writing
to investors. Issuers must furnish this written description to investors a reasonable time before the Rule 506 sale.

 

As of the date of this Memorandum, neither
the Company nor the Company’s Chief Executive Officer, nor the Director, nor any director, executive officer or other officer
of the Company participating in any offering of Securities of a private placement program sponsored by the Company is subject to
any of the “Bad Actor” disqualifications described in Rule 506(d) and (e) under the Act.

 

SUMMARY OF COMMON STOCK PURCHASE AGREEMENT

 

Each Member will be required to execute
a Common Stock Purchase Agreement, in the form attached hereto as Exhibit A. The investor should review the entire Subscription
Agreement before submitting an offer to purchase Common Stocks. The following is merely a summary of some of the significant provisions
of the Subscription Agreement and is qualified in its entirety by reference thereto.

 

Submission of Offer to Purchase

 

A summary of the escrow arrangements and
the process for subscribing to purchase Common Stocks is set forth in the Common Stock Purchase Agreement”. The investor
should read that Agreement in its entirety.

 

Termination of the Common Stock Purchase Agreement

 

The Common Stock Purchase Agreement may
be terminated if the conditions to the closing are not satisfied as set forth in the Common Stock Purchase Agreement. If a Subscription
Agreement is terminated, the Member will have no right to acquire any Common Stocks and will have no claims against the Company
for expenses, lost profits or otherwise.

 

 

 

    	 	15	 

     

    

 

ADDITIONAL INFORMATION

 

The financial projections and assertions
of market valuations included herein or incorporated by reference are based on the Odyessy’s current beliefs regarding the
expected costs and results of operations for the forecast period presented. Such financial projections and market valuations have
been prepared by the Company’s Chief Executive Officer based on assumptions as to revenues, expenses, cash flow and related
matters, and were prepared without any independent audit verification. They are subject to known and unknown risks, uncertainties
and assumptions that may cause actual results, costs, levels of activity, performance or achievements to be materially different
from any future results, levels of activity, costs, performance or achievements expressed or implied by such forward-looking statements.
If the Company’s underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual
results could vary materially from the exceptions and projections expressed or implied by the forward-looking statements.

 

The Chief Executive Officer will answer
inquiries from subscribers concerning the Company, its assets, investment objectives and strategies, and other matters relating
to the offer and sale of the Common Stocks. Also, the Company’s Chief Executive Officer will afford prospective investors
the opportunity to obtain any additional information to the extent the Company’s Chief Executive Officer possesses such information
or can acquire such information without unreasonable effort or expense that is necessary to verify the information in this Memorandum
and supplements to follow.

 

WHERE
YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a registration
statement on Form S-1 (including exhibits, schedules, and amendments) under the Securities Act with respect to the shares of Common
Stock offered by this prospectus. This prospectus does not contain all the information set forth in the registration statement.
For further information about us and the shares of common offered by this prospectus, you should refer to the registration statement.
Statements contained in this prospectus relating to the contents of any contract, agreement or other document are not necessarily
complete and are qualified in all respects by the complete text of the applicable contract, agreement or other document, a copy
of which has been filed as an exhibit to the registration statement. Whenever this prospectus refers to any contract, agreement,
or other document, you should refer to the exhibits that are a part of the registration statement for a copy of the contract, agreement,
or document.

 

We are subject to the reporting and information
requirements of the Exchange Act and, as a result, file, or will file, periodic reports, proxy statements and other information
with the SEC. These periodic reports and other information are available for inspection and copying at the SEC’s public reference
room and the website of the SEC, in each case, referred to below. We also maintain a website at http://www.odysseygi.com/ and make
available free of charge through this website our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on
Form 8-K and amendments to those reports filed or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act. We make these
reports available through our website as soon as reasonably practicable after we electronically file such reports with, or furnish
such reports to, the SEC. The information contained on, or that can be accessed through, our website is not a part of this prospectus.
The reference to our web address does not constitute incorporation by reference of the information contained in, or that can be
accessed through, our website.

 

You may read and copy this information
at the SEC’s Public Reference Room at 100 F Street, N.E., Washington D.C. 20549, on official business days during the hours
of 10:00 am to 3:00 pm. You may obtain information regarding the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.
The SEC also maintains a website (http://www.sec.gov) that contains reports, proxy and information statements and other information
regarding issuers that file electronically with the SEC.

 

DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR

SECURITIES LIABILITIES

 

Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers, and persons controlling us pursuant to the provisions
described in Item 14 of the registration statement of which this prospectus is a part or otherwise, we have been advised that in
the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
In the event that a claim for indemnification against such liabilities (other than our payment of expenses incurred or paid by
our directors, officers, or controlling persons in the successful defense of any action, suit, or proceeding) is asserted by our
directors, officers, or controlling persons in connection with the Common Stock being registered, we will, unless in the opinion
of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of the issue.

 

 

 

    	 	16	 

     

    

 

INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE

 

The SEC permits us to “incorporate
by reference” the information contained in documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents rather than by including them in this prospectus. Information that is incorporated by
reference is considered to be part of this prospectus and you should read it with the same care that you read this prospectus.
Information that we file later with the SEC will automatically update and supersede the information that is either contained, or
incorporated by reference, in this prospectus, and will be considered to be a part of this prospectus from the date those documents
are filed.

 

We incorporate by reference the documents
listed below, all filings filed by us pursuant to the Exchange Act after the date of the registration statement of which this prospectus
supplement forms a part, and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act
prior to the time that all Securities covered by this prospectus supplement have been sold; provided, however, that we are not
incorporating any documents or information deemed to have been furnished and not filed in accordance with SEC rules:

 

		·	our Annual Report on Form 10-K for the fiscal year ended July 31, 2020, filed with the SEC on November 16, 2020;

 

		·	our Quarterly Report on Form 10-Q for the quarter ended October 31, 2019, filed with the SEC on
December 11, 2020;

 

		·	our Current Reports on Form 8-K filed on August 4, 2020, August 6, 2020, August 14, 2020, August
17, 2020, August 19, 2020, October 15, 2020, October 27, 2020, November 19, 2020, December 15, 2020, January 8, 2021, January 11,
2021, January 26, 2021, and January 28, 2021;

 

		·	the description of our common stock contained in our Registration Statement on Form S-1, filed
on November 23, 2020, including any amendments thereto or reports filed for the purposes of updating this description.

 

		·	the description of our common stock contained in our Registration Statement on Form 8-A12G, filed
on August 14, 2020, including any amendments thereto or reports filed for the purposes of updating this description.

 

In addition, all documents subsequently
filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act before the date our offering is terminated or completed
are deemed to be incorporated by reference into, and to be a part of, this prospectus.

 

Any statement contained in this prospectus
or in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained in this prospectus or any other subsequently filed document
that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement so modified
or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.

 

We will provide to each person, including
any beneficial holder, to whom a prospectus is delivered, at no cost, upon written or oral request, a copy of any or all of the
information that has been incorporated by reference in the prospectus but not delivered with the prospectus. You should direct
any requests for copies to us at Attention: Secretary, 2372 Morse Ave., Irvine, California 92614 or you may call us at (619) 832-2900.
Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference into
this prospectus.

 

You should rely only
on information contained in, or incorporated by reference into, this prospectus. We have not authorized anyone to provide you with
information different from that contained in this prospectus, or incorporated by reference in this prospectus and in any free writing
prospectus that we have authorized for use in connection with this Offering. We are not making offers to sell the Securities in
any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such offer or solicitation
is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.

 

 

 

    	 	17	 

     

    

 

DESCRIPTION OF SECURITIES

 

The
Company is offering (the “Offering”) up to Three Million one Hundred Twenty-Five Thousand (3,125,000) Units
entitling the Investor to One (1) Share of the Company’s Common Stock to
be priced at a twenty percent (20%) discount to market priced on the close of trading on Tuesday, March 2, 2021. The price will
reflect the highest price traded on that day. The Company has set a floor of Eighty Cents ($0.80) per share and a ceiling and
their right to purchase One (1) Share of the Company’s Common Stock at a price of Two Dollars ($2.00) per share. The right
to purchase One (1) Share of the Company’s Common Stock at a price of Two Dollars ($2.00) per share terminates One (1) year
after the closing and acceptance of the Investors Common Stock Purchase Agreement.

 

No Involvement in Management

 

Holders of Common Stocks will have no involvement
in the management of the Issuer which will be managed entirely by the Company’s management team.

 

Distribution Policy

 

The Issuer has never paid any cash distributions
on its Common Stocks and does not anticipate or contemplate doing so in the foreseeable future. The Issuer intends to utilize all
of its available funds to develop its business. No assurances can be given that there will ever be excess funds available to pay
cash distributions.

 

Trading Market

 

The
Common Stocks purchasable under this Offering are restricted and can be sold only pursuant to an effective registration statement
that includes the Common Stocks or pursuant to an exemption from registration under the Securities Act and any applicable state
securities laws. As a result, the Common Stocks are illiquid and should only be purchased by persons who can afford to hold an
investment in the Common Stocks for an indefinite period of time. The Company is under no obligation to register the Common
Stocks under the Securities Act or any state securities laws, or to comply with any exemption available for the resale of Common
Stocks without registration.

 

The Securities
purchased will have a legend similar to the following:

 

“The Securities evidenced
by this certificate have not been registered under the United States Securities Act of 1933, as amended, and may not be sold, transferred,
assigned or hypothecated unless there is an effective registration statement under such Act covering such Securities, or the Issuer
receives an opinion of counsel for the holder of these Securities reasonably satisfactory to the Issuer, stating that such sale,
transfer, assignment or hypothecation is exempt from the registration and prospectus delivery requirements of such Act. Hedging
transactions including the Common Stock of the Company may not be conducted except in compliance with such Act.”

 

Indemnification of Chief Executive
Officers and Officers

 

Pursuant to Nevada Laws and our Corporation
Operating Agreement, the Company’s Chief Executive Officers and Officers of the Issuer will be indemnified to the maximum
extent allowed by law. Any repeal or modification of these provisions approved by the Issuer’s Board of Directors will be
prospective only, and will not adversely affect any limitation on the liability of a director or officer of the Issuer existing
as of the time of such repeal or modification. The Issuer may purchase insurance to fund its indemnification obligations.

 

EACH PROSPECTIVE INVESTOR SHOULD
CONSULT HIS, HER OR THE INVESTOR’S OWN TAX ADVISER CONCERNING THE IMPACT THAT HIS, HER OR ITS PARTICIPATION IN THE ISSUER
MAY HAVE ON HIS, HER OR ITS FEDERAL INCOME TAX LIABILITY AND THE APPLICATION OF STATE AND LOCAL INCOME AND OTHER TAX LAWS TO HIS,
HER OR ITS PARTICIPATION IN THIS OFFERING

 

 

 

    	 	18	 

     

    

 

ADDENDUM NO. 1 TO

 

 

 

Odyssey Group International Inc.

 

CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM

 

 

 

 

 

 

 

 

 

 

 

 

 

March
5, 2021 March 10, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-1	 

     

    

 

Addendum No. 1 to

 

Odyssey Group International Inc.

 

Private Placement Memorandum dated
February 23, 2021

 

 

 

 

The Company amends
its Private Placement Memorandum to include the following language and clarification.

 

In the Private Placement
Memorandum, the Company (“Odyssey,” the “Issuer,” the “Company,”), offered on a “No Minimum”
basis up to Three Million One Hundred Twenty-Five Thousand (3,125,000) Units consisting of an equal number of Shares of the Company’s
Common Stock per Unit at a purchase price per share of Common Stock to be priced at a twenty percent (20%) discount to market priced
on the close of trading on Tuesday, March 2, 2021. The price will reflect the highest price traded on that day. The Company has
set a floor of Eighty Cents ($0.80) per share and a ceiling of One Dollar ($1.00) price per share of restricted common stock and
warrants to purchase up to an equal number of Shares of the Company’s Common Stock per Unit shares of Common Stock at a per
share purchase price of Two Dollars ($2.00) per share. The warrants have a term of One (1) year.

 

Today, Tuesday, March
2, 2021, the Company’s stock traded at an intra-day high of One Dollar Forty Cents ($1.40) per share. A twenty percent (20%)
discount to highest traded price on on Tuesday, March 2, 2021 would be One Dollar Twelve Cents ($1.12) per share. The Company has
set a ceiling of One Dollar ($1.00) price per Unit. The Private Placement Memorandum is amended to reflect a price of One Dollar
($1.00) price per Unit each Unit consisting of a share of restricted common stock and a warrant to purchase up to an equal number
of Shares of the Company’s Common Stock per Unit shares of Common Stock at a per share purchase price of Two Dollars ($2.00)
per share. The warrants have a term of One (1) year.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-2	 

     

    

 

EXHIBIT “A”

 

STOCK SUBSCRIPTION AGREEMENT FORM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-3	 

     

    

 

SUBSCRIPTION DOCUMENTS FOR

 

ODYSSEY GROUP INTERNATIONAL, INC. COMMON
STOCK

 

CONFIDENTIAL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-4	 

     

    

 

DIRECTIONS FOR THE
COMPLETION OF THE SUBSCRIPTION DOCUMENTS

 

 

 

The Units of Odyssey Group
International, Inc. (the “Company”) is being offered to qualified investors pursuant to the Confidential Private
Placement Memorandum of the Company.

 

The Common Stocks have not
been registered under the Securities Act of 1933, as amended (the “1933 Act”), the Securities laws of any state
or the Securities laws of any other jurisdiction, nor is such registration contemplated. The Common Stocks will be offered and
sold under the exemption provided by Section 4(a)(2) of the 1933 Act, and other exemptions of similar import in the laws of the
states and other jurisdictions where the Offering will be made. The Company has elected to be treated as a business development
company under the Investment Company Act of 1940, as amended.

 

The distribution of this
Subscription Agreement and the offer and sale of the Common Stocks in certain jurisdictions may be restricted by law. This Subscription
Agreement does not constitute an offer to sell or the solicitation of an offer to buy any Common Stocks in any state or other jurisdiction
where, or to or from any person to or from whom, such offer or solicitation is unlawful or not authorized. The Common Stocks are
offered subject to the right of the Company to reject any subscription in whole or in part.

 

Prospective investors must
complete the Common Stock Purchase Agreement (the “Subscription Agreement”), the Investor Suitability Questionnaire
(the “Investor Suitability Questionnaire”) and any necessary attachments (the Subscription Agreement, the Investor
Suitability Questionnaire and all such attachments collectively, the “Subscription Documents”) contained in
this package in the manner described below. Capitalized terms not defined herein are used as defined in the Confidential Private
Placement Memorandum of Odyssey Group International, Inc., a Nevada Corporation (as amended from time to time). For purposes of
these Subscription Documents, the “Investor” is the person or entity for whose account the Common Stocks are
being purchased and that can satisfy the representations and warranties set forth in the Subscription Documents. Another person
or entity with investment authority may execute the Subscription Documents on behalf of Investor, but should indicate the capacity
in which it is doing so and the name of the Investor.

 

		1.	Common Stock Purchase Agreement:

 

		(a)	Each Investor should fill in the amount of the subscription payment (as
defined in the Subscription Agreement), date, print the name of the Investor and sign (and print name, capacity and title of signatory,
if applicable) on page 16.

 

		2.	Investor Suitability Questionnaire:

 

		(a)	In Section A, each Investor should fill in its name, type of entity, address,
tax identification or social security number, contact person(s), telephone and facsimile numbers, email address, and the other
requested information.

 

		(b)	Each Investor should check the box or boxes in Section B which are next to the category or categories
under which the Investor qualifies as an “Accredited Investor”.

 

		(c)	Each Investor that is an individual should respond to the questions in Section C.

 

		(d)	Each Investor that is an entity should provide the information and respond to the questions in
Section D.

 

		(e)	Each Investor should respond to the questions in Section E.

 

 

 

    	 	A-5	 

     

    

 

		(f)	Each Investor should respond to the questions in Section F.

 

		(g)	Print the name of the Investor and sign (and print name, capacity and title of signatory, if
applicable) on page 1 of the Investor Suitability Questionnaire.

 

		3.	Customer Identification Program — Documentation Requirements (if the documentation
may have previously been submitted, please contact the Company to confirm.)

 

		(a)	Formation:

 

Organized entities, including
corporations, partnerships, limited-liability companies, and trusts: provide a certificate of formation and formation agreement.

 

		(b)	Identification:

 

Investors who are natural
persons: provide a current (i.e., non-expired) copy of a government issued photo identification.

 

Corporations,
partnerships, limited-liability companies, and trusts: provide a current (i.e., non- expired) copy of a government
issued photo identification of natural persons who ultimately, directly or indirectly, benefit from 10% or more of the proceeds
of the entity or hold 10% or more of the control rights.

 

Upon review of the above
documents, the Company may require additional documentation in order to satisfy its requirements for Know Your Customer and its
compliance obligations under Anti-Money Laundering laws and regulations.

 

		4.	Tax Forms:

 

Each U.S. investor is required to fill
in and sign and date Form W-9 (see page 17) and each non-U.S. investor is required to fill in and date the relevant Form(s) W-8
(W-8BEN, W-8BEN-E, W-8IMY, W-8ECI or W-8EXP), as applicable, in accordance with the instructions to such Form, and in the event
that any applicable reduction or exemption from U.S. federal withholding tax is claimed, is required to provide all applicable
attachments or addendums as required to claim such exemption or reduction.

 

		5.	Evidence of Authorization:

 

Each Investor must provide
valid evidence of authorization, such as a list of authorized agents, and a current copy of a government issued photo identification
for the individual(s) authorized to sign the Subscription Documents.

 

		(a)	For Corporations:

 

Generally, Investors that
are corporations must submit certified corporate resolutions authorizing the subscription and identifying the corporate officer
empowered to sign the Subscription Documents.

 

		(b)	For Partnerships:

 

Partnerships must submit a
certified copy of the partnership certificate (in the case of limited partnerships) or partnership agreement identifying the general
partners.

 

 

 

    	 	A-6	 

     

    

 

		(c)	For Limited-Liability Companies:

 

Limited-liability companies
must submit a certified copy of the limited liability operating agreement or certificate of formation identifying the manager or
managing member, as applicable, empowered to sign the Subscription Documents.

 

		(d)	For Trusts:

 

Trusts must submit a copy of
the trust agreement.

 

		(e)	For Employee Benefit Plans:

 

Employee benefit plans
must submit a certificate of an appropriate officer certifying that the subscription has been authorized and identifying the individual
empowered to sign the Subscription Documents.

 

		6.	Delivery of Subscription Documents:

 

One digitally signed Portable
Document Format (PDF) sent via electronic mail or two original completed and executed copies of the Subscription Agreement and
the Investor Suitability Questionnaire, together with the Form W-9 or W-8, (W-8BEN, W-8BEN-E, W-8IMY, W-8ECI or W- 8EXP), as applicable,
and any required evidence of authorization, should be delivered to the Company at the address set forth below.

 

 

Inquiries regarding subscription
procedures (including if the Investor Suitability Questionnaire indicates that any Investor’s response to a question requires
further information) should be directed to the Issuer. If the Investor’s subscription is accepted (in whole or in part) by
the Company, a countersigned copy of this Subscription Agreement and other documents and instruments necessary to reflect the Investor’s
status as an investor in the Company, including any documents and instruments to be delivered pursuant to this Subscription Agreement,
will be delivered to the Investor promptly after the closing date at the address provided in the Subscription Documents.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-7	 

     

    

 

IRS Form W-9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	A-8	 

     

    

 

    	 	A-9	 

     

    

 

    	 	A-10	 

     

    

    	 	A-11	 

     

    

    	 	A-12	 

     

    

    	 	A-13	 

     

    

    	 	A-14	 

     

    

 

EXHIBIT “B”

 

INVESTOR QUESTIONNAIRE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	B-1	 

     

    

 

Odyssey Group International,
Inc.

 

Investor Suitability Questionnaire

 

 

 

Note:    Questions
regarding this questionnaire should be directed to the Issuer.

 

		A.	General Information

 

	1.     Print Full Name of Investor	 	Individual:	 
	 	 	 	 
	 	 	
        

        First Middle Last
	 
	 	 	 	 
	 	 	 	 
	 	 	
        

        Entity Name:
	 
	 	 	 	 
	 	 	Entity: To assist the Company in preparing the its tax filings, please check the category into which you fall:	 
	 	 	 	 
	 	 	Partnership	☐
	 	 	C-Corporation	☐
	 	 	S-Corporation	☐
	 	 	Estate	☐
	 	 	Grantor Trust	☐
	 	 	Trust-EIN (a trust with an EIN in this format: 12-3456789)	☐
	 	 	Trust-SSN (a trust with an EIN in this format: 123-45-6789)	☐
	 	 	IRA-EIN	☐
	 	 	IRA-SSN	☐
	 	 	Exempt Organization	☐
	 	 	LLP	☐
	 	 	LLC	☐
	 	 	Nominee-EIN	☐
	 	 	Nominee-SSN	☐
	 	 	Other	☐
	 	 	 	 
	2.     U.S. Taxpayer Identification or Social Security Number:	 	 	 
	 	 	 	 
	 	 	 	 

 

 

 

 

    	 	B-2	 

     

    
	 

                    

                    

	
         

        3.     Primary
        Contact Person for This Account and for General Notices:

         
	 
	Name: _________________________________	 	 	 
	 	 	 	 
	Address: _______________________________	 	 	 
	 	 	 	 
	_______________________________________	 	 	 
	 	 	 	 
	E-mail: ________________________________	 	 	 
	 	 	 	 
	Telephone: _____________________________ 	 	 	 
	 	 	 	 
	Fax:___________________________________	 	 	 

 

	4.     For distributions of cash, please wire funds to the following bank account:
	 
	Bank Name: ________________________________
	 
	Bank Location: ________________________________
	 
	Account Number: ________________________________
	 
	Account Name: ________________________________
	 
	Bank’s Routing
    No.: ________________________________
	 
	For further credit to (if any):________________________________
	 
	Reference: ________________________________
	 
	SWIFT Code: ________________________________
	
         

        5.     For distributions
        in-kind, please:

	 
	Credit securities to my brokerage account at the following firm: ________________________________
	 
	Firm Name: ________________________________
	 
	Address: ________________________________
	 
	Account Name: ________________________________
	 
	Account Number: _____________________________
	 
	DTC Number: ________________________________

 

 

 

    	 	B-3	 

     

    

 

	
         

        6.     Permanent
        Address of Investor:

        (if different from address

        for Notices above) ____________________________

	 
	___________________________________________
	 
	___________________________________________
	 
	7.     Contact Person(s) For This Account for Financial Information and Reporting (including quarterly and annual financial reports and capital account statements) (if different from address for Notices above):

 

	Name: ________________________________	 	Name: _________________________________
	 	 	 
	Address:______________________________	 	Address: _______________________________
	 	 	 
	_____________________________________	 	______________________________________
	 	 	 
	Telephone:____________________________	 	Telephone: _____________________________ 
	 	 	 
	Fax: _________________________________ 	 	Fax: ___________________________________ 
	 	 	 
	E-mail:_______________________________ 	 	E-mail: _________________________________ 

 

	
        

        8.     Contact
        Person(s) For This Account for Distribution Notices (if different from address for Notices above):

	 
	Name: ________________________________	Name: _________________________________
	 	 
	Address:______________________________	Address: _______________________________
	 	 
	_____________________________________	______________________________________
	 	 
	Telephone:____________________________	Telephone: _____________________________ 
	 	 
	Fax: _________________________________ 	Fax: ___________________________________ 
	 	 
	E-mail:_______________________________ 	E-mail: _________________________________ 

 

    	 	B-4	 

     

    

 

	
        

        9.     Contact
        Person for This Account for Legal Documentation (please limit to one contact) (if different from address for Notices above):

	 
	Name: ________________________________	Name: _________________________________
	 	 
	Address:______________________________	Address: _______________________________
	 	 
	_____________________________________	______________________________________
	 	 
	Telephone:____________________________	Telephone: _____________________________ 
	 	 
	Fax: _________________________________ 	Fax: ___________________________________ 
	 	 
	E-mail:_______________________________ 	E-mail: _________________________________ 
	 	 
	
        

        10.   Contact Person for This Account
        for Tax Matters (including Form 1099 distribution) (please limit to one contact) (if different from address for Notices above):

	 
	Name: _________________________________	 
	 	 
	Address: _______________________________	 
	 	 
	______________________________________	 
	 	 
	Telephone: _____________________________ 	 
	 	 
	Fax: ___________________________________ 	 
	 	 
	E-mail: ________________________________ 	 

 

		B.	Accredited Investor Status

 

The Investor represents and
warrants that the Investor is an “Accredited Investor” as defined in Rule 501 promulgated under Regulation D under
the United States Securities Act of 1933, as amended (the “1933 Act”). Please check as appropriate:

 

 

 

 

 

    	 	B-5	 

     

    

 

FOR INDIVIDUALS:

 

	☐	(A)	A natural person with individual net worth (or joint net worth with spouse) in excess of $1 million. For purposes of this item, “net worth” means the excess of total assets at fair market value, including automobiles and other personal property and property owned by a spouse, but excluding the value of the primary residence of such natural person, over total liabilities. For this purpose, the amount of any mortgage or other indebtedness secured by an Investor’s primary residence should not be included as a “liability”, except to the extent the fair market value of the residence is less than the amount of such mortgage or other indebtedness.
	 	 	 
	☐	(B)	A natural person with individual income (without including any income of the Investor’s spouse) in excess of $200,000, or joint income with spouse in excess of $300,000, in each of the two most recent years and who reasonably expects to reach the same income level in the current year.

 

FOR ENTITIES:

 

	☐	(A)	An entity, including a grantor trust, in which all of the equity owners are Accredited Investors (for this purpose, a beneficiary of a trust is not an equity owner, but the grantor of a grantor trust may be an equity owner).
	 	 	 
	☐	(B)	A bank as defined in Section 3(a)(2) of the 1933 Act, or any savings-and-loan association or other institution as defined in Section 3(a)(5)(A) of the 1933 Act whether acting in its individual or fiduciary capacity.
	 	 	 
	☐	(C)	An insurance company as defined in Section 2(a)(13) of the 1933 Act.
	 	 	 
	☐	(D)	A broker-dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended (the “1934 Act”).
	 	 	 
	☐	(E)	An investment company registered under the Investment Company Act of 1940, as amended (the “1940 Act”).
	 	 	 
	☐	(F)	A business development company as defined in Section 2(a)(48) of the 1940 Act.
	 	 	 
	☐	(G)	A Small Business Investment Company licensed by the Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 	 
	☐	(H)	A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended (the “Advisers Act”).
	 	 	 
	☐	(I)	A corporation, an organization described in Section 501(c)(3) of the United States Internal Revenue Code of 1986, as amended, Massachusetts or similar business trust, or partnership, in each case not formed for the specific purpose of acquiring Common Stocks, with total assets in excess of $5 million.
	 	 	 
	☐	(J)	A trust with total assets in excess of $5 million not formed for the specific purpose of acquiring Common Stocks, whose purchase is directed by a person with such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Common Stocks.
	 	 	 
	☐	(K)	An employee
    benefit plan within the meaning of the United States Employee Retirement Income Security Act of 1974, as amended
    (“ERISA”) if the decision to invest in the Common Stocks is made by a plan fiduciary, as defined in Section 3(21) of ERISA, which is either a bank, savings-and-loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5 million or, if a self-directed plan, with investment decisions made solely by persons that are Accredited Investors.
	 	 	 
	☐	(L)	
        A plan established and maintained by a state, its
        political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of

        its employees, if the plan has total assets in excess
        of $5 million.

 

 

 

    	 	B-6	 

     

    

 

		C.	Supplemental Data for Individuals

 

		2.	Date of Birth: _______________________________________

 

		3.	Please indicate whether you are investing the assets of any retirement plan, employee benefit plan
or other similar agreement (such as an IRA or “Keogh” plan).

 

		☐	Yes ☐No

 

If the above question was answered “Yes,”
please submit additional information with respect to such plan including applicable documents granting you authority to invest
assets of such retirement plan.

 

		4.	If the above question was answered “No,” are you a person who has discretionary authority
or control with respect to the Company’s assets or provides investment advice for a fee (direct or indirect) with respect
to such assets, or a person directly or indirectly through one or more intermediaries, controlling any such person?

 

		☐	Yes ☐No

 

		D.	Supplemental Data for Entities

 

		1.	If the Investor is not a natural person, the Investor must furnish the following supplemental data (Natural persons may skip
this Section of the Investor Suitability Questionnaire):

 

Legal form of entity (trust, corporation, partnership,
limited-liability company, etc.):

 

____________________________________________________________________________________________

 

 

Jurisdiction of organization and location of domicile:

 

Is the Investor (a) a trust any
portion of which is treated (under subpart E of part I of subchapter J of chapter 1 of subtitle A of the Code) as owned by a natural
person (e.g., a grantor trust), (b) an entity disregarded for federal income tax purposes and owned (or treated as owned)
by a natural person or a trust described in clause (a) of this sentence (e.g., a limited-liability company with a single
member), (c) an organization described in Sections 401(a) or 501 of the Code or (d) a trust permanently set aside or to be used
for a charitable purpose?

 

		☐	Yes ☐No

 

Is the Investor acting on behalf of an unrelated third
party (e.g., nominee arrangement)?

 

		☐	Yes ☐No

 

If “Yes,” please describe the arrangement:
_____________________________

 

 

 

    	 	B-7	 

     

    

 

Does the Investor have one or more ultimate beneficiaries who (a) are entitled to 10% or more of the proceeds from this investment
or (b) hold 10% or more of the control rights of the Investor?

 

		☐	Yes ☐No

 

Is the Investor or any of the
ultimate beneficiaries publicly traded?

 

		☐	Yes ☐No

 

Is the Investor or any of the
ultimate beneficiaries a regulated entity?

 

		☐	Yes ☐No

 

If the
response to any of the above questions is “yes,” please complete the below chart. If there is insufficient space in
the chart, please include additional sheets of paper with the relevant information.

 

	Name of Investor and Each 10% Beneficial Owner	If the Investor or Any of the 10% Beneficial Owners Is Publicly Traded, Please Identify the Exchange for the Public Trading.	If the Investor or Any of the 10% Beneficial Owners Is a Regulated Entity, Please Identify Regulator and Jurisdiction.
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

		2.	Was the Investor organized for the specific purpose of acquiring Common Stocks?

 

		☐	Yes ☐No

 

		3.	a. Is the Investor a grantor trust, a partnership or an S-Corporation for U.S. federal income tax purposes?

 

		☐	Yes ☐No

 

		3.	b. If the question above was answered “Yes,” please indicate whether or not:

 

(i)     
more than 50 percent of the value of the ownership interest of any beneficial owner in the Investor is (or may at any time
during the term of the Company be) attributable to the Investor’s (direct or indirect) interest in the Company; or

 

		☐	Yes ☐No

 

 

 

 

    	 	B-8	 

     

    

 

(ii)   
it is a principal purpose of the Investor’s participation in the Company to permit any entity to satisfy the 100 partner
limitation contained in U.S. Treasury Regulation Section 1.7704-l(h)(3).

 

		☐	Yes ☐No

 

If either question above was answered
“Yes,” please submit appropriate organizational documents, trust documents, or partnership or operating agreement stating,
among other things, the powers of authority and signature(s).

 

		4.	Are shareholders, partners or other holders of equity or beneficial interests in the Investor able
to decide individually whether to participate, or the extent of their participation, in the Investor’s investment in the
Company (i.e., can shareholders, partners or other holders of equity or beneficial interests in the Investor determine whether
their capital will form part of the capital invested by the Investor in the Company)?

 

		☐	Yes ☐No

 

If the above question was answered
“Yes,” please submit relevant documents evidencing that the shareholders, partners or other holders of equity or beneficial
interests in the Investor have agreed to for their capital to form part of the capital invested by the Investor in the Company.

 

		5.	a. Please indicate whether or not the Investor is, or is acting (directly or indirectly) on behalf
of, (i) an employee benefit plan (within the meaning of Section 3(3) of ERISA), whether or not such plan is subject to Title I
of ERISA, (ii) a plan, individual retirement account or other arrangement that is described in Section 4975 of the Code, whether
or not such plan, account or arrangement is subject to Section 4975 of the Code, (iii) an insurance company using general account
assets, if such general account assets are deemed to include the assets of any of the foregoing types of plans, accounts or arrangements
for purposes of Title I of ERISA or Section 4975 of the Code under Section 401(c)(1)(A) of ERISA or the regulations promulgated
thereunder, or (iv) an entity whose assets are deemed to include the assets of any of the foregoing types of plans, accounts or
arrangements (each of the foregoing described in clauses (i), (ii), (iii) and (iv) being referred to as a “Plan Investor”).

 

		☐	Yes ☐No

 

		5.	b. If the Investor is, or is acting (directly or indirectly) on behalf of, such a Plan Investor,
please indicate whether or not the Plan Investor is subject to Title I of ERISA or Section 4975 of the Code.

 

		☐	Yes ☐No

 

		5.	c. If the answer to question 5.b. above is “Yes”, please indicate what percentage of
the Plan Investor’s assets invested in the Company are the assets of “benefit plan investors” within the meaning
of Section 3(42) of ERISA as modified by 29 CFR 2510.3-101(f):

 

Percentage: ________________

 

		5.	d. If the Investor is investing the assets of an insurance company general account, please indicate
what percentage of the insurance company general account’s assets invested in the Company are the assets of “benefit
plan investors” within the meaning of Section 401(c)(1)(A) of ERISA or the regulations promulgated thereunder:

 

Percentage: ________________

 

 

 

    	 	B-9	 

     

    

 

		5.	e. If the Plan Investor is not subject to Title I of ERISA or Section 4975 of the Code, please
indicate whether or not such Plan Investor is subject to any other federal, state, local, non-U.S. or other laws or regulations
that could cause the underlying assets of the Company to be treated as assets of the Plan Investor by virtue of its investment
in the Company and thereby subject the Company and/or the Chief Executive Officer or Board of Directors (or other persons responsible
for the investment and operation of the Company’s assets) to laws or regulations that are similar to the fiduciary responsibility
or prohibited transaction provisions contained in Title I of ERISA or Section 4975 of the Code.

 

		☐	Yes ☐No

 

		5.	f. If the answer to question 5.a. above is “No,” please indicate whether the Investor
is a person who has discretionary authority or control with respect to the Company’s assets or provides investment advice
for a fee (direct or indirect) with respect to such assets, or an affiliate of any such person. For this purpose, an “affiliate”
of a person includes any person, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under
common control with, such person. “Control” with respect to a person other than an individual means the power to exercise
a controlling influence over the management or policies of such person.

 

		☐	Yes ☐No

 

		6.	a. Is the Investor a private investment company which is not registered under the 1940 Act in reliance on:

 

Section 3(c)(1) thereof? ☐ Yes
☐ No

 

Section 3(c)(7) thereof?  ☐ Yes
☐ No

 

		6.	b. If the Investor answered “Yes” to any part of question 6.a. please indicate whether
or not the Investor was formed on or before April 30, 1996.

 

		☐	Yes ☐No

 

		6.	c. If question 6.b. was answered “Yes,” please indicate whether or not the Investor
has obtained the consent of its direct and indirect beneficial owners to be treated as a “qualified purchaser” as provided
in Section 2(a)(51)(C) of the 1940 Act and the rules and regulations thereunder.

 

		☐	Yes ☐No

 

If question 6.c. was answered
“No,” please contact the Company for additional information that will be required in order to obtain the consent to
be treated as a “qualified purchaser” as provided in Section 2(a)(51(C) of the 1940 Act and rules regulations thereunder.

 

		6.	d. Does the amount of the Investor’s subscription payment exceed 40% of the total assets
(on a consolidated basis with its subsidiaries) of the Investor?

 

		☐	Yes ☐No

 

 

 

    	 	B-10	 

     

    

 

		7.	Is the Investor an “investment company” registered or required to be registered under
the 1940 Act, as amended?

 

		☐	Yes ☐No

 

		8.	If the Investor’s tax year ends on a date other than December 31, please indicate such date below:

 

______________________________________

 

		9.	Is the Investor subject to the U.S. Freedom of Information Act, 5 U.S.C. § 552, (“FOIA”),
any state public records access laws, any state or other jurisdiction’s laws similar in intent or effect to FOIA, or any
other similar statutory or regulatory requirement that might result in the disclosure of confidential information relating to the
Company?

 

		☐	Yes ☐No

 

If the question above was answered “Yes,”
please indicate the relevant laws to which the Investor is subject and provide any additional explanatory information in the space
below:

 

___________________________________________________________________________

 

___________________________________________________________________________

 

___________________________________________________________________________

 

 

		10.	a.
                                         If the Investor is an entity substantially owned by a “government entity”1
                                         (e.g., a single investor vehicle) and the investment decisions of such entity
                                         are made or directed by such government entity, please provide the name of the government
                                         entity: _________________________________

 

_________________________

 

1 Any U.S. state or political subdivision of a U.S.
state, including:

		(i)	Any agency, authority, or instrumentality of the U.S. state or political subdivision;

		(ii)	A pool of assets sponsored or established by the U.S. state or political subdivision or any agency,
authority or instrumentality thereof, including, but not limited to a “defined benefit plan” as defined in Section
414(j) of the Internal Revenue Code (26 U.S.C. 414(j)), or a U.S. state general fund;

 

Please note that, if the Investor enters the name of a government
entity in response to this question 10.a., the Company will treat the Investor as if it were the government entity for purposes
of Rule 206(4)-5 of the Investment Advisers Act (the “Pay to Play Rule”).

 

 

 

 

 

 

    	 	B-11	 

     

    

 

		10.	b.    If the Investor is (i) a government entity, (ii) acting as trustee, custodian or nominee
for a beneficial owner that is a government entity, or (iii) an entity described in question 10.a., the Investor hereby certifies
that:

 

		☐	other than the Pay to Play Rule, no “pay to play” or other similar compliance obligations
would be imposed on the Company, the Chief Executive Officer or Board of Directors or their affiliates in connection with the Investor’s
subscription;

 

- OR -

 

		☐	If the Investor cannot make the above certification, indicate in the space below all other “pay
to play” laws, rules or guidelines, or lobbyist disclosure laws or rules, the Company, the Chief Executive Officer or Board
of Directors or their affiliates or employees would be subject to in connection with the Investor’s subscription:

 

		E.	Related Parties/Other Beneficial Parties:

 

		1.	To the best of the Investor’s knowledge, does the Investor control, or is the Investor controlled
by or under common control with, any other investor or prospective Investor in the Company?

 

		☐	Yes ☐No

 

If the question above was answered
“Yes,” please indicate the name of such other investor in the space below:

 

_________________________________________

 

		2.	Will any other person or persons have a beneficial interest in the Common Stocks to be acquired
hereunder (other than as a shareholder, partner, policy owner or other beneficial owner of equity interests in the Investor)? (By
way of example, and not limitation, “nominee” Investors or Investors who have entered into swap or other synthetic
or derivative instruments or arrangements with regard to the Common Stocks to be acquired herein would check “Yes”)

 

		☐	Yes ☐No

 

If either question above was answered
“Yes,” please provide identifying information for person or persons having a beneficial interest in the Common Stocks
to be acquired hereunder.

 

		F.	BHC Investor Status:

 

Is the Investor a “BHC Investor”?2

 

_______________________________

 

		(iii)	Any participant-directed investment program or plan sponsored or established by a U.S. state or
political subdivision or any agency, authority or instrumentality thereof, including, but not limited to, a “qualified tuition
plan” authorized by Section 529 of the Internal Revenue Code (26 U.S.C. 529), a retirement plan

authorized by Section 403(b) or 457 of the Internal
Revenue Code (26 U.S.C. 403(b) or 457), or any similar program or plan; and

		(iv)	Officers, agents, or employees of the U.S. state or political subdivision or any agency, authority or instrumentality thereof,
acting in their official capacity.

 

2
A “BHC Investor” is defined as an Investor that is a bank holding company, as defined in Section 2(a) of the Bank Holding
Company Act of 1956, as amended (the “BHC Act”), a non-bank subsidiary (for purposes of the BHC Act) of a bank
holding company, a foreign banking organization, as defined in Regulation K of the Board of Governors of the Federal Reserve System
(12 C.F.R. § 211.23) or any successor regulation, or a non-bank subsidiary (for purposes of the BHC Act) of a foreign banking
organization which subsidiary is engaged, directly or indirectly in business in the United States and which in any case holds Common
Stocks for its own account.

 

		☐	Yes ☐No

 

[Remainder of Page Intentionally Left Blank]

 

 

 

    	 	B-12	 

     

    

 

The Investor
understands that the foregoing information will be relied upon by the Company for the purpose of determining the eligibility of
the Investor to purchase and own Common Stocks in the Company. The Investor agrees to notify the Company immediately if any representation
or warranty contained in this Subscription Agreement or any of the information in the Investor Suitability Questionnaire becomes
untrue at any time. The Investor agrees to provide, if requested, any additional information that may reasonably be required to
substantiate the Investor’s status as an Accredited Investor, or to otherwise determine the eligibility of the Investor to
purchase Common Stocks in the Company. To the fullest extent permitted by law, the Investor agrees to indemnify and hold harmless
the Company, the Administrator, the Chief Executive Officer or Board of Directors and each partner or member thereof, from and
against any loss, damage or liability due to or arising out of a breach of any representation, warranty or agreement of the Investor
contained herein.

 

	 	Signatures: INDIVIDUAL:
	 	 
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	 
	 	(Print Name)
	 	 
	 	PARTNERSHIP, CORPORATION, LIMITED-LIABILITY COMPANY,
TRUST, CUSTODIAL ACCOUNT, OTHER:
	 	 
	 	 
	 	(Name of Entity)
	 	 
	 	 
	 	By:___________________________________________ 
	 	(Signature)
	 	 
	 	 
	 	(Print Name and Title)

 

 

 

 

    	 	B-13	 

     

    

 

Appendix B: Transfer
Restrictions

 

No Transfer of the Investor’s
subscription payment or all or any fraction of the Investor’s Common Stocks may be made without (i) registration of the Transfer
on the Company books and (ii) the prior written consent of the Chief Executive Officer or Board of Directors . In any event, the
consent of the Chief Executive Officer or Board of Directors may be withheld (x) if the creditworthiness of the proposed transferee,
as determined by the Chief Executive Officer or Board of Directors in its sole discretion, is not sufficient to satisfy all obligations
under the Subscription Agreement or (y) unless, in the opinion of counsel (who may be counsel for the Company or the Investor)
satisfactory in form and substance to the Company:

 

		·	such Transfer would not violate the Securities Act or any state (or other
jurisdiction) securities or “Blue-Sky” laws applicable to the Company or the Common Stocks to be Transferred; and

 

		·	such Transfer would not be a “prohibited transaction” under
ERISA or the Code or the regulations promulgated thereunder or cause all or any portion of the assets of the Company to constitute
“plan assets” under ERISA, certain Department of Labor regulations or Section 4975 of the Code.

 

The Investor agrees that it
will pay all reasonable expenses, including attorneys’ fees, incurred by the Company in connection with any Transfer of all
or any fraction of its Common Stocks, prior to the consummation of such Transfer.

 

Any person that acquires
all or any fraction of the Common Stocks of the Investor in a Transfer permitted under this Appendix B shall be obligated to pay
to the Company the appropriate portion of any amounts thereafter becoming due in respect of the subscription payment committed
to be made by its predecessor in interest. The Investor agrees that, notwithstanding the Transfer of all or any fraction of its
Common Stocks, as between it and the Company, it will remain liable for its subscription payment and for all payments of any Drawdown
Purchase Price required to be made by it (without taking into account the Transfer of all or a fraction of such Common Stocks)
prior to the time, if any, when the purchaser, assignee or transferee of such Common Stocks, or fraction thereof, becomes a holder
of such Common Stocks.

 

The Company shall not recognize
for any purpose any purported Transfer of all or any fraction of the Common Stocks and shall be entitled to treat the transferor
of Common Stocks as the absolute owner thereof in all respects, and shall incur no liability for distributions or dividends made
in good faith to it, unless the Company shall have given its prior written consent thereto and there shall have been filed with
the Company a dated notice of such Transfer, in form satisfactory to the Company, executed and acknowledged by both the seller,
assignor or transferor and the purchaser, assignee or transferee, and such notice (i) contains the acceptance by the purchaser,
assignee or transferee of all of the terms and provisions of this Subscription Agreement and its agreement to be bound thereby,
and (ii) represents that such Transfer was made in accordance with this Subscription Agreement, the provisions of the Memorandum
and all applicable laws and regulations applicable to the transferee and the transferor.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	B-14	 

     

    

 

Appendix C: United
States Person

 

The term “United States Person” means a
person described in one or more of the following paragraphs:

 

		1.	With respect to any person, any individual or entity that would be a United
States Person under Regulation S promulgated under the 1933 Act. The Regulation S definition is set forth below.

 

		2.	With respect to individuals, any U.S. citizen or “resident alien”
within the meaning of U.S. income tax laws as in effect from time to time. Currently, the term “resident alien” is
defined under U.S. income tax laws to generally include any individual who (i) holds an Alien Registration Card (a “green
card”) issued by the U.S. Immigration and Naturalization Service or (ii) meets a “substantial presence” test.
The “substantial presence” test is generally met with respect to any current calendar year if (a) the individual was
present in the U.S. on at least 31 days during such year and (b) the sum of the number of days on which such individual
was present in the U.S. during the current year, 1/3 of the number of such days during the first preceding year, and 1/6 of the
number of such days during the second preceding year, equals or exceeds 183 days.

 

		3.	With respect to persons other than individuals:

 

		a.	a corporation or partnership created or organized in the United States or
under the laws of any political subdivision thereof;

 

		b.	a trust where (a) a U.S. court is able to exercise primary supervision over
the administration of the trust and (b) one or more United States Persons have the authority to control all substantial decisions
of the trust; and

 

		c.	an estate which is subject to U.S. tax on its worldwide income from all sources.

 

Set forth below is the definition of “United
States Person” contained in Regulation S under the 1933 Act.

 

		1.	“United States Person” means:

 

		a.	Any natural person resident in the United States;

 

		b.	Any partnership or corporation organized or incorporated under the laws of the United States;

 

		c.	Any estate of which any executor or administrator is a United States Person;

 

		d.	Any trust of which any trustee is a United States Person;

 

		e.	Any agency or branch of a non-United States entity located in the United States;

 

		f.	Any non-discretionary account or similar account (other than an estate
or trust) held by a dealer or other fiduciary for the benefit of a United States Person;

 

		g.	Any discretionary account or similar account (other than an estate or trust)
held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and

 

		h.	Any partnership or corporation if: (A) organized or incorporated under
the laws of any jurisdiction other than the United States; and (B) formed by a United States Person principally for the purpose
of investing in securities not registered under the Securities Act unless it is organized or incorporated, and owned, by “Accredited
Investors” (as defined in Rule 501(a) under the Securities Act) who are not natural persons, estates or trusts.

 

 

 

    	 	B-15	 

     

    

 

		2.	The following are not “United States Persons”

 

		a.	any discretionary account or similar account (other than an estate or trust)
held for the benefit or account of a non-United States Person by a dealer or other professional fiduciary organized, incorporated,
or (if an individual) resident in the United States shall not be deemed to be a “United States Person”;

 

		b.	any estate of which any professional fiduciary acting as executor or administrator
is a United States Person shall not be deemed to be a “United States Person” if: (i) an executor or administrator of
the estate who is not a United States Person has sole or shared investment discretion with respect to the assets of the estate;
and (ii) the estate is governed by laws other than those of the United States;

 

		c.	any trust of which any professional fiduciary acting as trustee is a United
States Person shall not be deemed to be a “United States Person” if a trustee who is not a United States Person has
sole or shared investment discretion with respect to the trust assets, and no beneficiary of the trust (and no settlor if the trust
is revocable) is a United States Person;

 

		d.	an employee benefit plan established and administered in accordance with
(i) the laws of a country other than the United States and (ii) the customary practices and documentation of such country, shall
not be deemed to be a “United States Person”;

 

		e.	any agency or branch of a United States Person located outside the United
States shall not be deemed a “United States Person” if: the agency or branch (i) operates for valid business reasons,
(ii) is engaged in the business of insurance or banking, and (iii) is subject to substantive insurance or banking regulation, respectively,
in the jurisdiction where located; and

 

		f.	none of the International Monetary Fund, the International Bank for Reconstruction
and Development, the Inter-American Development Bank, the Asian Development Bank, the African Development Bank, the United Nations,
or their agencies, affiliates and pension plans, or any other similar international organization, or its agencies, affiliates and
pension plans, shall be deemed to be a “United States Person”.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	B-16	 

     

    

 

EXHIBIT “C”

 

WIRE INSTRUCTIONS

 

 

 

 

 

 

 

PLEASE
MAKE CHECKS PAYABLE TO: Odyssey Group International, Inc. and send to:

 

Odyssey Group International, Inc.

 

865 NE Tomahawk Island Dr. #188

 

Portland, OR 97217

 

Or

 

Wire funds to the following bank account:

 

Odyssey Group International, Inc.

 

Fifth Third Bank

 

38 Fountain Square Plaza

 

Cincinnati, OH 45263

 

Account #7927256763

 

Routing #042000314

 

 

 

 

 

 

 

 

 

 

 

 

    	 	C-1	 

     

    

 

EXHIBIT “D”

 

ANTI-MONEY LAUNDERING REQUIREMENTS

 

The USA PATRIOT Act

 

The USA PATRIOT Act is designed to detect,
deter, and punish terrorists in the United States and abroad. The Act imposes new Anti-Money Laundering requirements on brokerage
firms and financial institutions. Since April 24, 2002 all brokerage firms have been required to have new, comprehensive Anti-Money
Laundering programs.

 

To help the investor understand these efforts,
the Company want to provide the investor with some information about money laundering and our steps to implement the USA PATRIOT
Act.

 

What is Money Laundering?

 

Money laundering is the process of disguising
illegally obtained money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in connection
with a wide variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.

 

How big is the problem and why is it
important?

 

The use of the U.S. financial system by
criminals to facilitate terrorism or other crimes could well taint our financial markets. According to the U.S. State Department,
one recent estimate puts the amount of worldwide money laundering activity at $1 trillion a year.

 

What are the Company required to do
to eliminate money laundering?

 

Under
rules required by the USA PATRIOT Act, our Anti-Money Laundering program must designate a special compliance officer, set up employee
training, conduct independent audits, and establish policies and procedures to detect and report suspicious transactions and ensure
compliance with such laws. As part of our required program, the Company may ask the investor to provide various identification
documents or other information. the Company will ask the investor for your name, address, date of birth and other information
that will allow the Company to identify you. the Company will ask to see a non-expired valid issued government identification,
such as your driver’s license or other identifying documents. Until the investor provide the information or documents the
Company need, the Company may not be able to effect any transactions for you.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	D-1	 

     

    

 

ANTI-MONEY LAUNDERING INFORMATION FORM

 

The Following is Required in Accordance
with the AML Provision of the USA PATRIOT ACT.

(Please fill out and return with requested
documentation.)

 

 

	INVESTOR NAME:	 	 
	 	 	 
	 	 	 
	LEGAL ADDRESS:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	SSN# or TAX ID# 	 	 
	OF INVESTOR:	 	 
	 	 	 
	FOR INVESTORS WHO ARE INDIVIDUALS:	 

 

	YEARLY INCOME: ____________________	AGE: ______	 
	 	 	 	 

	 	 	 
	NET WORTH:__________________________________________________________________________________
    *	 

 

 

		·	For purposes of calculating your net worth in this form, (a) your primary residence shall
not be included as an asset; (b) indebtedness secured by your primary residence, up to the estimated fair market value of your
primary residence at the time of your purchase of the Securities, shall not be included as a liability (except that if the amount
of such indebtedness outstanding at the time of your purchase of the Securities exceeds the amount outstanding 60 days before such
time, other than as a result of the acquisition of your primary residence, the amount of such excess shall be included as a liability);
and (c) indebtedness that is secured by your primary residence in excess of the estimated fair market value of your primary residence
at the time of your purchase of the Securities shall be included as a liability.

 

 

	OCCUPATION: 	 	 
	 	 	 
	 	 	 
	ADDRESS OF EMPLOYER:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	INVESTMENT OBJECTIVE(S):	 	 
	 	 	 
	 	 

 

 

 

    	 	D-2	 

     

    

 

IDENTIFICATION AND DOCUMENTATION
AND SOURCE OF FUNDS:

 

		1.	Please submit a copy of non-expired identification for the authorized signatory(ies) on the investment
documents, showing name, date of birth, address and signature. The address shown on the identification document MUST match the
Investor’s address shown on the Investor Signature Page.

 

	Current Driver’s License	or	Valid Passport	or	Identity Card
	 	 	 	 	 

(Circle one or more)

 

		2.	If the Investor is a corporation, limited liability company, trust or other type of entity, please
submit the following requisite documents: (i) Articles of Formation, By-Laws, Certificate of Formation, Operating Agreement, Trust
or other similar documents for the type of entity; and (ii) Corporate Resolution or power of attorney or other similar document
granting authority to signatory(ies) and designating that they are permitted to make the proposed investment.

 

		3.	Please advise where the funds were derived from to make the proposed investment:

 

	Investments	Savings	Proceeds of Sale	Other ____________

 

(Circle one or more)

 

 

Signature: _________________________________________

 

 

Print Name: ________________________________________

 

 

Title (if applicable): __________________________________

 

 

Date: _____________________________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	D-3Exhibit 10.6

 

COMMON STOCK PURCHASE AGREEMENT

 

THIS AGREEMENT is made
and entered into this 5th day of March 2021, by and between Odyssey Group International, Inc. a Nevada corporation, with its principle
place of business at 2372 Morse Ave, Irvine California 92614 (“Seller”) and the undersigned with a principal address
set forth below. (“Buyer”).

 

WHEREAS Seller
is the record owner and holder of the capital stock of Odyssey Group International, Inc. (“Seller” and “Corporation”),
a Nevada corporation, which Corporation has authorized five hundred million (500,000,000) shares of Common stock (“Shares”)
and issued capital stock of approximately ninety-two million (92,000,000) shares of $.001 par value Common Stock; and

 

WHEREAS the
Seller agrees to sell to Buyer a number of Shares of said stock that as specified in Exhibit “A” hereto (the “Selling
Shares”); and

 

WHEREAS Buyer
desires to purchase the number of shares of said stock at a price specified in Exhibit “A” hereto (the “Buying
Shares”) and the Seller desires to sell the Shares, upon the terms and subject to the conditions hereinafter set forth.

 

WHEREAS, subject
to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchaser,
and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1                          
Definitions. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Warrant (as defined herein), and (b) the following terms have the meanings
set forth in this Section 1.1:

 

“Acquiring
Person” shall have the meaning ascribed to such term in Section 4.7.

 

“Action”
shall have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediary, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

 

 

    	 	1	 

     

    

 

“Closing
Date” means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii)
the Company’s obligations to deliver the Securities have been satisfied or waived.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed into.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive Common Stock.

 

“Company”
means Odyssey Group International, Inc.

 

“Company
Counsel” means Brinen & Associates, LLC.

 

“Exercise
Price” shall have the meaning ascribed to such term in the Warrant.

 

“Disclosure
Schedules” shall have the meaning ascribed to such term in Section 3.1.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exempt
Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, or directors of the Company
pursuant to any stock or option plan or agreement duly adopted for such purpose by the Board of Directors or a majority of the
members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise, exchange or conversion
of any other securities, options, warrants, convertible securities or other rights to acquire, exercisable or exchangeable for
or convertible into, shares of Common Stock, in each case that are issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise, exchange or conversion price of such securities, (c) securities issued pursuant to acquisitions of companies, assets
or intellectual property (or licensing of assets or intellectual property) or strategic transactions approved by a majority of
the disinterested directors of the Company, if any, provided that any such issuance shall only be to a Person which is, itself
or through its subsidiaries, an operating company, a university or other non-financial institution and in which the Company receives
benefits in addition to the investment of funds, (d) securities issued or issuable in exchange for consideration other than cash
in connection with any other transaction that is not for the primary purpose of financing the Company’s business, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity
whose primary business is investing in securities.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Indebtedness”
shall have the meaning ascribed to such term in Section 3.1(aa).

 

“Intellectual
Property Rights” shall have the meaning ascribed to such term in Section 3.1(o).

 

“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

“Liens”
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

 

 

    	 	2	 

     

    

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material
Permits” shall have the meaning ascribed to such term in Section 3.1(m).

 

“Maximum
Rate” shall have the meaning ascribed to such term in Section 5.17.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited-liability
company, joint-stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Purchaser
Party” shall have the meaning ascribed to such term in Section 4.10.

 

“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

“Required
Minimum” means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the Transaction Documents, including any Underlying Shares issuable upon exercise of the Warrant, ignoring
any conversion or exercise limits set forth therein.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).

 

“Securities”
means the Warrant and the Underlying Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

 

“Subscription
Amount” means the aggregate amount to be paid for the Securities purchased hereunder as specified below the Purchaser’s
name on the signature page of this Agreement and next to the heading “Subscription Amount,” in United States dollars
and in immediately available funds.

 

“Subsidiary”
means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where applicable, include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

 

 

    	 	3	 

     

    

 

“Trading
Market” means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE MKT, LLC, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York
Stock Exchange, or the OTC QB maintained by the OTC Markets Group, Inc.

 

“Transaction
Documents” means this Agreement, the Warrant, all exhibits and schedules thereto and hereto and any other documents or
agreements executed in connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means Issuer Direct and any successor transfer agent of the Company.

 

“Underlying
Shares” means the shares of Common Stock issuable upon exercise of the Warrants.

 

“Warrant”
means that one-year warrant to purchase an equal amount of shares of Common Stock of the Company at an exercise price equal to
Two Dollars ($2.00) per share, issued by the Company to the Purchaser hereunder, in the form of Exhibit B attached hereto.

 

ARTICLE II.

PURCHASE AND SALE

 

2.1                          
Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent
with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchaser agrees to
purchase, for a purchase price set forth below and amount of shares set forth below for shares of restricted Common Stock of the
Company. The Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to its Subscription Amount
and the Company shall deliver to the Purchaser its Shares, as determined pursuant to Section 2.2(a), and the Company and the Purchaser
shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the conditions set forth
in Sections 2.2 and 2.3, the initial Closing shall occur at the offices of Brinen & Associates, LLC or such other location
as the parties shall mutually agree.

 

2.2                           
Deliveries.(a)On the Closing Date, the Company shall deliver or cause to be delivered
to each Purchaser the following:

 

		(i)	this Agreement duly executed by the Company; and

 

		(ii)	Resolutions of the Board of Directors of the Company approving this transaction and all Transaction Documents.

 

		(b)	On the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i)        this
Agreement duly executed by the Purchaser; and

 

 (ii)        such Purchaser’s Subscription Amount by wire transfer to the account as specified in writing by the Company. (See Annex A)

 

 

 

    	 	4	 

     

    

 

2.3                           
Closing Conditions.

 

(a)           
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met,
unless waived in the sole and absolute discretion of the Company:

 

(i)       
the accuracy in all material respects on the Closing Date of the representations and warranties of the Purchaser contained
herein;

 

(ii)       
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall
have been performed; and

 

(iii)      
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

 

(b)           
The obligations of the Purchaser hereunder in connection with the Closing are subject to the following conditions being
met, unless waived in the sole and absolute discretion of the Purchaser:

 

(i)        
the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Company
contained herein;

 

(ii)       
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall
have been performed;

 

(iii)      
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement; and

 

(iv)      
there shall have been no Material Adverse Effect with respect to the Company since the date hereof.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1           
Representations and Warranties of the Company.Except as set forth in the Disclosure
Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein
to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the
following representations and warranties to each Purchaser:

 

(a)      
Subsidiaries. The Company’s Subsidiaries are set forth on Schedule 3.1(a) and the Company owns, directly or
indirectly, the capital stock or other equity interests of each Subsidiary, in the amounts set forth on Schedule 3.1(a), free and
clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are
fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

(b)      
Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with
the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of
the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on
the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations,
assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii)
a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under
any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been
instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.

 

 

 

    	 	5	 

     

    

 

(c)       
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required
by the Company, the Board of Directors or the Company’s stockholders in connection therewith other than in connection with
the Required Approvals. Each Transaction Document to which it is a party has been (or upon delivery will have been) duly executed
by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation
of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(d)       
No Conflicts. The execution, delivery and performance by the Company of the Transaction Documents and the consummation
by it to which it is a party of the other transactions contemplated hereby and thereby do not and will not: (i) conflict with or
violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time
or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or
any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse
of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise)
or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any
Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have
or reasonably be expected to result in a Material Adverse Effect.

 

(e)       
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i) the filings required pursuant to Section 4.6, (ii) such consents, waivers, or authorizations as have been obtained
before the Closing, (iii) if required, the notice and/or application(s) to each applicable Trading Market for the issuance and
sale of the Securities and the listing of the Underlying Shares for trading thereon in the time and manner required thereby and
(iv) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws
(collectively, the “Required Approvals”).

 

(f)       
Issuance of the Securities. The issuance of the Common Stock and Warrant has been duly authorized and, when issued
and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.
The Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid
and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction
Documents. The Company has reserved from its duly authorized capital stock a number of shares of Common Stock for issuance of the
Underlying Shares.

 

(g)       
Capitalization. The capitalization of the Company immediately prior to Closing is, in all material respects, as set
forth in the SEC Reports. Except as provided on Schedule 3.1(g), or the SEC Reports, no Person has (i) any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents except for such, if any, as will have been validly waived before the Closing and (ii) except pursuant to
the operation of agreements filed as exhibits to the SEC Reports before the date of this Agreement, the issuance and sale of the
Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchaser)
and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price
under any of such securities. All of the outstanding shares of capital stock of the Company are validly issued, fully paid and
nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was
issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or
authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. Except
as filed as exhibits to the SEC Reports, there are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among
any of the Company’s stockholders.

 

 

 

    	 	6	 

     

    

 

(h)      
SEC Reports; Financial Statements. Except as set forth on Schedule 3.1(h) hereto, the Company has filed all
reports, schedules, forms, statements and other documents required to be filed by the Company under Section 15(d) of the Exchange
Act for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file
such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension, except as set forth on Schedule
3.1(h). As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in
the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with generally
accepted accounting principles (“GAAP”), except as may be otherwise specified in such financial statements or
the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present
in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.

 

(i)        
Material Changes. Except as provided in Schedule 3.1(i), since the date of the latest financial statements
included in the SEC Reports: (i) there has been no event, occurrence or development that has had or that could reasonably be expected
to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the
Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem
any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company equity incentive plans. The Company does not have pending before the Commission any request
for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event,
liability or development has occurred or exists with respect to the Company or its Subsidiaries or their respective business, properties,
operations or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the
time this representation is made or deemed made that has not been publicly disclosed at least one Trading Day prior to the date
that this representation is made.

 

(j)         Litigation.
Except as disclosed in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local
or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or
officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state
securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not
pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(k)        Labor
Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’
employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective-bargaining agreement, and the Company and its Subsidiaries
believe that their relationships with their employees are good. No executive officer, to the knowledge of the Company, is, or
is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of
any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. To the Company’s knowledge, the Company and its Subsidiaries
are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

 

 

    	 	7	 

     

    

 

(l)        
Compliance. To the Company’s knowledge, neither the Company nor any Subsidiary: (i) is in default under or
in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in
a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is
in default under or that it is in violation of, any indenture, loan or credit agreement or any other material agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) is in violation of any order of any court, arbitrator or governmental body or (iii) is or has been in violation of any statute,
rule or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws applicable
to its business and all such laws that affect the environment, except in each of the foregoing cases as could not have or reasonably
be expected to result in a Material Adverse Effect.

 

(m)      
Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued
by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.

 

(n)       
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property
and good and marketable title in all personal property owned by it that, in each case, is material to the business of the Company
and the Subsidiaries, in each case free and clear of all Liens, except for Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties
in any material respect. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them
under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.

 

(o)        Patents
and Trademarks. To the Company’s knowledge (without having conducted any independent investigation): (i) the Company
and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
as described in the SEC Reports as necessary or material for use in connection with their respective businesses and which the
failure to so have could reasonably be expected to have a Material Adverse Effect (collectively, the “Intellectual Property
Rights”); (ii) neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of the Intellectual
Property Rights violates or infringes upon the rights of any Person; (iii) all such Intellectual Property Rights are enforceable
and there is no existing infringement by another Person of any of the Intellectual Property Rights, except where the failure to
be so enforceable or for such infringements as would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect; and (iv) the Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.

 

(p)       
Transactions with Affiliates and Employees. Except as set forth in the SEC Reports, none of the officers or directors
of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement
for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock
option plan of the Company.

 

(q)      
Environmental Laws. The Company and its subsidiaries are (i) in compliance with any and all applicable foreign, federal,
state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits, licenses or
other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except in each of the above cases where noncompliance could
not be reasonably expected to have a Material Adverse Effect.

 

 

 

    	 	8	 

     

    

 

(r)       
Sarbanes-Oxley; Internal Accounting Controls. Except as set forth in the SEC Reports, the Company is in material
compliance with all provisions of the Sarbanes-Oxley Act of 2002 which are applicable to it as of the Closing Date. The Company
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
Company and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness of
the Company’s disclosure controls and procedures as of the end of the period covered by the Company’s most recently
filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its
most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of
the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no changes in the Company’s internal control over financial reporting (as such term is defined in the Exchange Act)
that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial
reporting.

 

(s)      
Certain Fees. Except as disclosed on Schedule 3.1(t), no brokerage or finder’s fees or commissions are
or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank
or other Person with respect to the transactions contemplated by the Transaction Documents,. The Purchaser shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in
this Section that may be due in connection with the transactions contemplated by the Transaction Documents.

 

(t)        
Private Placement. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section
3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser
as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the
Trading Market.

 

(u)       
Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for
the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become subject to the Investment
Company Act of 1940, as amended.

 

(v)       
Registration Rights. Except as disclosed in the SEC Reports, no Person has any right to cause the Company to effect
the registration under the Securities Act of any securities of the Company.

 

(w)      
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements.

 

(x)       
Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any,
in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under
a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar
charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchaser as a result of
the Purchaser and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including
without limitation as a result of the Company’s issuance of the Securities and the Purchaser’s ownership of the Securities.

 

 

 

    	 	9	 

     

    

 

(y)      
Disclosure. Except with respect to (i) the material terms and conditions of the transactions contemplated by the
Transaction Documents and (ii) information given to the Investor, if any, which the Company hereby confirms will not constitute
material nonpublic information six months from the date hereof, the Company confirms that neither it nor any other Person acting
on its behalf has provided the Purchaser or their agents or counsel with any information that it believes constitutes or might
constitute material, nonpublic information. The Company understands and confirms that the Purchaser will rely on the foregoing
representation in effecting transactions in securities of the Company. All disclosure furnished in writing by or on behalf of the
Company to the Purchaser regarding the Company, its business and the transactions contemplated hereby, including the Disclosure
Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made,
not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken
as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that the Purchaser has not made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(z)       
No Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth in
Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of the Securities Act which would
require the registration of any such securities under the Securities Act.

 

(aa)     
Tax Status.  Except for matters that would not, individually or in the aggregate, have or reasonably be expected
to result in a Material Adverse Effect, the Company and each Subsidiary has filed all necessary federal, state and foreign income
and franchise tax returns and has paid or accrued all taxes shown as due thereon, and the Company has no knowledge of a tax deficiency
which has been asserted or threatened against the Company or any Subsidiary.

 

(bb)    
No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any
of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only
to the Purchaser and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

(cc)     
Foreign Corrupt Practices. Neither the Company, nor to the knowledge of the Company, any agent or other person acting
on behalf of the Company, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose
fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is
in violation of law or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

(dd)    
No Disagreements with Accountants and Lawyers; Outstanding SEC Comments. There are no disagreements of any kind presently
existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently
employed by the Company and the Company is or immediately after the Closing Date will be current with respect to any fees owed
to its accountants which could affect the Company’s ability to perform any of its obligations under any of the Transaction
Documents. There are no unresolved comments or inquiries received by the Company or its Affiliates from the Commission which remain
unresolved as of the date hereof.

 

 

 

    	 	10	 

     

    

 

(ee)     
Acknowledgment Regarding Purchaser’s Purchase of Securities. The Company acknowledges and agrees that the Purchaser
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice
given by the Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the
transactions contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further
represents to the Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents
has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(ff)      
Disqualification. No executive officer, member of the Board of Directors of the Company or shareholder of the Company
beneficially owning more than 10% of the Company’s securities is currently subject to a Disqualifying Event. For purposes
of this Agreement, “Disqualifying Event” means any conviction, order, judgment, decree, suspension, expulsion, event
or other matter set out in Rule 506(d)(1)(i) through (viii) of Regulation D that is currently in effect or which occurred within
the periods set out in Rule 506(d)(1)(i) through (viii).

 

3.2                           
Representations and Warranties of the Purchaser. The Purchaser hereby represents and warrants as of the date hereof
and as of the Closing Date to the Company as follows:

 

(a)       
Organization; Authority. The Purchaser is an entity duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization with full right, corporate or partnership power and authority to enter into and to
consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated
by the Transaction Documents have been duly authorized by all necessary corporate or similar action on the part of the Purchaser.
Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in
accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against
it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b)      
Own Account. The Purchaser understands that the Securities are “restricted securities” and have not been
registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its
own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the
Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting the Purchaser’s
right to sell the Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state
securities laws) in violation of the Securities Act or any applicable state securities law. The Purchaser is acquiring the Securities
hereunder in the ordinary course of its business.

 

(c)       
Purchaser Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is,
and on each date on which it converts any Securities it will be either: (i) an “accredited investor” as defined in
Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer”
as defined in Rule 144A(a) under the Securities Act. The Purchaser is not required to be registered as a broker-dealer under Section
15 of the Exchange Act.

 

(d)       
Experience of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic
risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)      
General Solicitation. The Purchaser is not purchasing the Securities as a result of any advertisement, article, notice
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or any other general solicitation or general advertisement.

 

 

 

    	 	11	 

     

    

 

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

4.1                           
Transfer Restrictions.

 

(a)       
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or in connection with a pledge
as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel
selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under
the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement,
including the representations and warranties made by each Purchaser herein, and shall have the rights of a Purchaser under this
Agreement.

 

(b)      
The Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities
in the following form:

 

THIS SECURITY HAS BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE
TO THE COMPANY. THIS SECURITY MAY NOT BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

The Company
acknowledges and agrees that the Purchaser may from time to time grant a security interest in some or all of the Securities to
a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who
agrees in writing with the Company to be bound by the provisions of this Agreement and, if required under the terms of such arrangement
and subject to compliance with applicable federal and state securities laws, the Purchaser may transfer secured Securities to the
secured parties. Absent special circumstances, such a transfer would not be subject to approval of the Company and no legal opinion
of legal counsel of the secured party shall be required in connection therewith. At the Purchaser’s expense, the Company
will execute and deliver such reasonable documentation as a secured party of Securities may reasonably request in connection with
a pledge or transfer of the Securities.

 

(c)       
Certificates evidencing the Underlying Shares (or, if Underlying Shares are issued in uncertificated form, comparable share
notices) shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement
covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such Underlying Shares
pursuant to Rule 144, or (iii) if such Underlying Shares are eligible for sale under Rule 144, without the requirement for the
Company to be in compliance with the current public information required under Rule 144 as to such Underlying Shares and without
volume or manner-of-sale restrictions, or (iv) if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission), as reasonably determined by
the Company. Upon the Purchaser’s request in connection with a proposed sale of Underlying Shares pursuant to Rule 144 and
if the Company reasonably determines it is so required, upon receipt of customary documentation from Purchaser’s broker (if
the Underlying Shares are sold in brokers transactions), the Company shall, at its own cost and effort, retain legal counsel to
provide an opinion letter to the Company’s transfer agent opining that the Underlying Shares may be resold without registration
under the Securities Act, pursuant to Rule 144, promulgated thereunder, so long as the requirements of Rule 144 are met for any
Underlying Shares to be resold thereunder. The Company shall arrange for any such opinion letter to be provided not later than
two (2) business days after the date of delivery to and receipt by the Company of a written request by the Purchaser together with
(if required in order to render the opinion) any broker’s representation letter of other customary documentation reasonably
requested by the Company evidencing compliance with Rule 144 (the “Legend Removal Date”).

 

 

 

    	 	12	 

     

    

 

(d)      
The Purchaser agrees that the Purchaser will sell any Securities only pursuant to either an exemption from registration
or a registration statement under the Securities Act, including any applicable prospectus delivery requirements, and that if Securities
are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein,
and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section
4.1 is predicated upon the Company’s reliance upon this understanding.

 

4.2                          
Acknowledgment of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of
the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further
acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying
Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim,
delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against the Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.

 

4.3                          
Furnishing of Information. Until the earlier to occur of the time that (i) the Purchaser owns no Securities, or (ii)
18 months from the date hereof, the Company covenants that it will maintain the registration of the Common Stock under Section
12(b) or 12(g) of the Exchange Act and to use all commercially reasonable efforts to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant
to the Exchange Act. As long as the Purchaser owns Securities, if the Company is not required to file reports pursuant to the Exchange
Act, it will prepare and furnish to the Purchaser and make publicly available in accordance with Rule 144(c) such information as
is required for the Purchaser to sell the Securities under Rule 144. The Company further covenants that it will use all commercially
reasonable efforts to take such further action as any holder of Securities may reasonably request, to the extent required from
time to time to enable such Person to sell such Securities without registration under the Securities Act within the requirements
of the exemption provided by Rule 144.

 

4.4                           
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect
of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities
to the Purchaser in a manner that would require the registration under the Securities Act of the sale of the Securities to the
Purchaser.

 

4.5                          
Conversion and Exercise Procedures. The form of Notice of Exercise included in the Warrants sets forth the totality
of the procedures required of the Purchaser in order to exercise the Warrants. No additional legal opinion, other information or
instructions shall be required of the Purchaser exercise the Warrants. The Company shall honor exercise of the Warrants and shall
deliver Underlying Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.6                          
Securities Laws Disclosure; Publicity. The Company shall, by 8:30 a.m. (New York City time) on the third (3rd) Trading
Day immediately following the date hereof, issue a Current Report on Form 8-K disclosing the material terms of the transactions
contemplated hereby and including the Transaction Documents as exhibits thereto. The Company and the Purchaser shall consult with
each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor
the Purchaser shall issue any such press release nor otherwise make any such public statement (other than in the Company’s
SEC Reports after the Closing Date or exhibits filed therewith) without the prior consent of the Company, with respect to any press
release of the Purchaser, or without the prior consent of the Purchaser, with respect to any press release of the Company, which
consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing
party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
other than in connection with the Company’s SEC Reports or disclosures to any regulatory agency or Trading Market that the
Company determines are necessary or appropriate, the Company shall not publicly disclose the name of the Purchaser, or include
the name of the Purchaser, in any press release or similar public statement, without the prior written consent of the Purchaser.

 

4.7                          
Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any
other Person, that the Purchaser is an “Acquiring Person” under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect, or that
the Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under
the Transaction Documents or any other agreement between the Company and the Purchaser.

 

 

 

    	 	13	 

     

    

 

4.8                          
Nonpublic Information. Except with respect to the material terms and conditions of the transactions contemplated
by the Transaction Documents, the Company covenants and agrees that after the Closing Date neither it, nor any other Person acting
on its behalf, will provide the Purchaser or its agents or counsel with any information that the Company believes constitutes material
nonpublic information, unless prior thereto the Purchaser shall have executed a written agreement regarding the confidentiality
and use of such information. The Company understands and confirms that the Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company. Purchaser acknowledges that it is aware that the United States securities
laws prohibit any person who has material nonpublic information about a company from purchasing or selling securities of such company,
or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such
person is likely to purchase or sell such securities, and Purchaser agrees not to engage in any unlawful trading in securities
of the Company or unlawful misuse or misappropriation of any such information. Purchaser agrees to maintain the confidentiality
of and not disclose or use (except for purposes relating to the transactions contemplated by this Agreement) any confidential,
proprietary or nonpublic information disclosed by the Company to Purchaser.

 

4.9                           
Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital
purposes and shall not use such proceeds for: (a) the satisfaction of any portion of the Company’s debt (other than payment
of trade payables in the ordinary course of the Company’s business and prior practices), (b) the redemption of any Common
Stock or Common Stock Equivalents or (c) the settlement of any outstanding litigation.

 

4.10                        
Indemnification of Purchaser. Subject to the provisions of this Section 4.10, the Company will indemnify and hold
the Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person
who controls the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the
directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling person (each,
a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages,
costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to any action, suit, claim
or proceeding brought by a third party against such Purchaser Party arising out of or relating to (a) any breach of any of the
representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents
or (b) any action instituted against a Purchaser in any capacity, or any of them or their respective Affiliates, by any stockholder
of the Company who is not an Affiliate of the Purchaser, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is based upon a breach of such Purchaser’s representations, warranties or covenants under the
Transaction Documents or any agreements or understandings the Purchaser may have with any such stockholder or any violations by
the Purchaser of state or federal securities laws or any conduct by the Purchaser which constitutes fraud, gross negligence, willful
misconduct or malfeasance). If any action shall be brought against the Purchaser Party in respect of which indemnity may be sought
pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right
to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party
shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and
to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on
any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall
be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to
any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior
written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants
or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents.

 

 

 

    	 	14	 

     

    

 

4.11                         
Reservation and Listing of Securities.

 

(a)       
The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction
Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.

 

(b)       
If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the
Required Minimum on such date, then the Board of Directors shall use commercially reasonable efforts to amend the Company’s
certificate or articles of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the
Required Minimum at such time, as soon as possible and in any event not later than the 75th calendar day after such date.

 

(c)       
The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file
with such Trading Market an additional shares listing application covering a number of shares of Common Stock at least equal to
the Required Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be
approved for listing on such Trading Market as soon as possible thereafter, (iii) provide to the Purchaser evidence of such listing
and (iv) maintain the listing of such Common Stock on any date at least equal to the Required Minimum on such date on such Trading
Market or another Trading Market.

 

4.12                         
Form D; Blue-Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof, promptly upon request of the Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchaser
at the Closing under applicable securities or “Blue-Sky” laws of the states of the United States, and shall provide
evidence of such actions promptly upon request of the Purchaser.

 

4.13                         
Transfer Agent. The Company covenants and agrees that it will at all times will maintain a duly qualified independent
transfer agent.

 

4.14                         
No Short Selling. The Purchaser has and shall not, directly or indirectly, his, her or itself, through related parties,
affiliates or otherwise, (i) sell “short” or “short against the box” (as those terms are generally understood)
any equity security of the Company or (ii) otherwise engage in any transaction that involves hedging of the Purchaser’s position
in any equity security of the Company.

 

ARTICLE V.

MISCELLANEOUS

 

5.1                          
Termination. This Agreement may be terminated by the Purchaser, as to the Purchaser’s obligations hereunder
only and without any effect whatsoever on the obligations between the Company and the Purchaser, by written notice to the other
parties, if the Closing has not been consummated on or before June 5, 2018; provided, however, that such termination
will not affect the right of any party to sue for any breach by the other party (or parties).

 

5.2                          
Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such
party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all
transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchaser.

 

5.3                          
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral
or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

 

 

    	 	15	 

     

    

 

5.4                           
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of: (a) one Trading Day after the date of transmission,
if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto
prior to 5:30 p.m. (New York City time) on a Trading Day, with written confirmation of successful transmission, (b) the next Trading
Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth
on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto.

 

5.5                          
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a
written instrument signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right.

 

5.6                          
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not
be deemed to limit or affect any of the provisions hereof.

 

5.7                          
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of the Purchaser (other than by merger). The Purchaser may assign any or all of its rights under this Agreement to any
Person to whom the Purchaser assigns or transfers any Securities, provided that such transfer complies with all applicable federal
and state securities laws and that such transferee agrees in writing with the Company to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the Purchaser.

 

5.8                           
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
except as otherwise set forth in Section 4.10.

 

5.9                          
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction
Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without
regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought
against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in Clark County, Nevada. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in Clark County, Nevada for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or
proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such action or proceeding shall
be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.

 

 

 

    	 	16	 

     

    

 

5.10                         
Survival. The representations and warranties shall survive the Closing and the delivery of the Securities, at which
time they shall expire such respect to Purchaser and shall no longer be of any force or effect.

 

5.11                         
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such facsimile or “.pdf” signature page were an original thereof.

 

5.12                        
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

5.13                        
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any
similar provisions of) any of the other Transaction Documents, whenever the Purchaser exercises a right, election, demand or option
under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided,
then the Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however,
that in the case of a rescission of an exercise of a Warrant, the Purchaser shall be required to return any shares of Common Stock
subject to any such rescinded conversion or exercise notice.

 

5.14                        
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in
the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under
such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance
of such replacement Securities.

 

5.15                        
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, each of the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agrees to waive and not to assert in any action for specific performance of any
such obligation the defense that a remedy at law would be adequate.

 

5.16                        
Saturdays, Sundays, Holidays, etc.If the last or appointed day for the taking of any action or the expiration
of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised
on the next succeeding Business Day.

 

5.17                        
Construction. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be
resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
hereto.

 

5.18                         
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY
OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY,
UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

 

 

    	 	17	 

     

    

 

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	
        Company

         

         
	
        Address for Notice:

         

        Odyssey Group International, Inc.

        2372 Morse Ave.

        Irvine, California 92614

         

	
        By: /s/ J. Michael Redmond

        Name: J. Michael Redmond

        Title: Chief Executive Officer

         

         

        With a copy to (which shall not constitute notice):
	
        E-Mail: michael@odysseygi.com

         

	
        Name: Christine M. Farrell

        Title: Chief Financial Officer

         
	
        E-Mail: chris@odysseygi.com

         

 

 

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	18	 

     

    

 

[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF,
the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.

 

 

Name of Purchaser: _____________________________________________________________

 

Signature of Authorized Signatory of
Purchaser: ______________________________________

 

Name of Authorized Signatory: ____________________________________________________

 

Title of Authorized Signatory: _____________________________________________________

 

Email Address of Authorized Signatory:
DonaldKiepert@gmail.com

 

Facsimile Number of Authorized Signatory: __________________________________________

 

If Individual, then please sign and print on the first two
lines.

 

 

 

Address for Notice of Purchaser:

 

 

 

Address for Delivery of Securities for Purchaser (if not same
as address for notice):

 

 

 

 

 

Subscription Amount in Shares: ________

 

 

Subscription Amount in Dollars

at One Dollar ($1.00) per Share: ________

 

 

 

 

EIN Number: __________

 

[SIGNATURE PAGES CONTINUE]

 

 

 

    	 	19	 

     

    

 

 

Exhibit A

 

Subscription Amount 

 

 

 

 

 

Subscription Amount in Shares: _________

 

 

Subscription Amount in Dollars

at One Dollar ($1.00) per Share: _________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	20	 

     

    

 

 

Exhibit B

 

WARRANT AGREEMENT

 

(See Attached)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	21	 

     

    

 

Annex A

 

WIRE INSTRUCTIONS:

 

PLEASE MAKE CHECKS PAYABLE TO: Odyssey
Group International, Inc. and send to:

 

Odyssey Group International, Inc.

 

865 N.E. Tomahawk Island Drive #188

 

Portland, Oregon 97217

 

Or

 

Wire funds to the following bank account:

 

Odyssey Group International, Inc.

 

Fifth Third Bank

 

38 Fountain Square Plaza

 

Cincinnati, OH 45263

 

Account #7927256763

 

Routing # 042000314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	22	 

     

    

 

SCHEDULE 3.1(a)

 

List of Subsidiaries

 

	Name of Entity	Jurisdiction of Incorporation	Ownership

 

None.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	23	 

     

    

 

SCHEDULE 3.1(g)

Participation Rights

 

None.

 

 

SCHEDULE 3.1(h)

SEC Reports

 

All Reports have been filed with the Securities
and Exchange Committee.

 

 

SCHEDULE 3.1(i)

Material Changes

 

None.

 

 

SCHEDULE 3.1(t)

Certain Fees

 

None.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]